CK2A2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A0MZ66 | T475 | Sugiyama | SHTN1 KIAA1598 | tLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADsssP |
| O00170 | S43 | Sugiyama | AIP XAP2 | GELPDFQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELI |
| O00203 | S276 | Sugiyama | AP3B1 ADTB3A | FVSPWKEGDELEDNGKNFyEsDDDQKEKTDKKKKPYTMDPD |
| O00264 | S181 | Sugiyama | PGRMC1 HPR6.6 PGRMC | TFKYHHVGKLLKEGEEPtVysDEEEPKDEsARKND______ |
| O00264 | S57 | Sugiyama | PGRMC1 HPR6.6 PGRMC | LCIFLLYKIVRGDQPAAsGDsDDDEPPPLPRLKRRDFtPAE |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O00566 | S167 | Sugiyama | MPHOSPH10 MPP10 | EMGERAENSSKsDLRKsPVFsDEDsDLDFDISKLEQQSKVQ |
| O00566 | S171 | Sugiyama | MPHOSPH10 MPP10 | RAENSSKsDLRKsPVFsDEDsDLDFDISKLEQQSKVQNKGQ |
| O00567 | S520 | Sugiyama | NOP56 NOL5A | sIsFsKPKKKKsFsKEELMssDLEEtAGstsIPKRKKstPK |
| O00629 | S60 | Sugiyama | KPNA4 QIP1 | KRDEHLLKRRNVPHEDICEDsDIDGDYRVQNtsLEAIVQNA |
| O14950 | T135 | Sugiyama | MYL12B MRLC2 MYLC2B | TGTIQEDYLRELLttMGDRFtDEEVDELyREAPIDKKGNFN |
| O14958 | S385 | SIGNOR|iPTMNet | CASQ2 | VLSGKINTEDDDEDDDDDDNsDEEDNDDsDDDDDE______ |
| O15173 | T211 | Sugiyama | PGRMC2 DG6 PMBP | KEKYDYVGRLLKPGEEPsEytDEEDtKDHNKQD________ |
| O15350 | T27 | PSP | TP73 P73 | TSPDGGTTFEHLWSSLEPDStyFDLPQSSRGNNEVVGGTDs |
| O15460 | S346 | Sugiyama | P4HA2 UNQ290/PRO330 | PFKEEDEWDSPHIVRYyDVMsDEEIERIKEIAKPKLARATV |
| O43150 | S701 | Sugiyama | ASAP2 DDEF2 KIAA0400 | FNSHVHVEYEWRLLHEDLDEsDDDMDEKLQPSPNRREDRPI |
| O43583 | T86 | Sugiyama | DENR DRP1 H14 | AKLtVENsPKQEAGIsEGQGtAGEEEEKKKQKRGGRGQIKQ |
| O43719 | S529 | Sugiyama | HTATSF1 | KNDCEENGLAKEsEDDLNKEsEEEVGPTKESEEDDSEKESD |
| O43719 | S561 | Sugiyama | HTATSF1 | EDDSEKESDEDCSEKQsEDGsEREFEENGLEKDLDEEGsEK |
| O43719 | S597 | Sugiyama | HTATSF1 | EGsEKELHENVLDKELEENDsENsEFEDDGsEKVLDEEGsE |
| O43719 | S600 | Sugiyama | HTATSF1 | EKELHENVLDKELEENDsENsEFEDDGsEKVLDEEGsEREF |
| O43719 | S642 | Sugiyama | HTATSF1 | EDsDEKEEEEDtyEKVFDDEsDEKEDEEyADEKGLEAADKK |
| O43719 | S676 | Sugiyama | HTATSF1 | LEAADKKAEEGDADEKLFEEsDDKEDEDADGKEVEDADEKL |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | S277 | Sugiyama | CALU | WILPsDyDHAEAEARHLVyEsDQNKDGKLTKEEIVDKyDLF |
| O43852 | Y275 | Sugiyama | CALU | KDWILPsDyDHAEAEARHLVyEsDQNKDGKLTKEEIVDKyD |
| O43896 | S1092 | SIGNOR|ELM|iPTMNet | KIF1C KIAA0706 | RPPGPRYPPYttPPRMRRQRsAPDLKESGAAV_________ |
| O60220 | S96 | Sugiyama | TIMM8A DDP DDP1 TIM8A | FILNRLEQTQKSKPVFSEsLsD___________________ |
| O60231 | S103 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | AEREARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRK |
| O60231 | S106 | Sugiyama | DHX16 DBP2 DDX16 KIAA0577 PRP2 | EARALLEKNRSYRLLEDsEEssEEtVsRAGsSLQKKRKKRK |
| O60341 | S131 | Sugiyama | KDM1A AOF2 KDM1 KIAA0601 LSD1 | sRRKRAKVEyREMDEsLANLsEDEyysEEERNAKAEKEKKL |
| O60343 | S485 | Sugiyama | TBC1D4 AS160 KIAA0603 | CERIEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPV |
| O60343 | T488 | Sugiyama | TBC1D4 AS160 KIAA0603 | IEGLYPPRAKLVIQRHLssLtDNEQADIFERVQKMKPVSDQ |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60832 | S485 | Sugiyama | DKC1 NOLA4 | LIKKEKKKSKKDKKAKAGLEsGAEPGDGDsDttKKKKKKKK |
| O60841 | S113 | Sugiyama | EIF5B IF2 KIAA0741 | sKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTAKPKVEM |
| O60841 | S135 | Sugiyama | EIF5B IF2 KIAA0741 | ELEDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKAQ |
| O60841 | S137 | Sugiyama | EIF5B IF2 KIAA0741 | EDKDsKSKKTAKPKVEMysGsDDDDDFNKLPKKAKGKAQKS |
| O60841 | S164 | Sugiyama | EIF5B IF2 KIAA0741 | NKLPKKAKGKAQKSNKKWDGsEEDEDNsKKIKERsRINssG |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O60841 | S190 | Sugiyama | EIF5B IF2 KIAA0741 | NsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKNKPGP |
| O60841 | S214 | Sugiyama | EIF5B IF2 KIAA0741 | LQsRKGQKKNQKNKPGPNIEsGNEDDDAsFKIKTVAQKKAE |
| O60885 | S601 | Sugiyama | BRD4 HUNK1 | SNVSKKEPAPMKsKPPPtYEsEEEDKCKPMSYEEKRQLSLD |
| O60927 | S77 | Sugiyama | PPP1R11 HCGV TCTE5 | ssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHRKG |
| O60936 | T149 | SIGNOR | NOL3 ARC NOP | RASDPDEAGGPEGsEAVQsGtPEEPEPELEAEAsKEAEPEP |
| O75116 | S937 | Sugiyama | ROCK2 KIAA0619 | ITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMARH |
| O75379 | S30 | ELM | VAMP4 | NDDDVTGsVKsERRNLLEDDsDEEEDFFLRGPSGPRFGPRN |
| O75391 | S114 | Sugiyama | SPAG7 | sFGEDDDCRYVMIFKKEFAPsDEELDSYRRGEEWDPQKAEE |
| O75400 | S938 | Sugiyama | PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225 | SPKKKtGKDsGNWDtsGsELsEGELEKRRRtLLEQLDDDQ_ |
| O75822 | S127 | Sugiyama | EIF3J EIF3S1 PRO0391 | VLtPEEQLADKLRLKKLQEEsDLELAKEtFGVNNAVyGIDA |
| O76094 | S610 | Sugiyama | SRP72 | KKGKKKDQIGKGtQGAtAGAssELDAsKtVssPPtsPRPGs |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95218 | S188 | Sugiyama | ZRANB2 ZIS ZNF265 | KLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRRSRSKSRS |
| O95340 | S180 | Sugiyama | PAPSS2 ATPSK2 | VKGLYKRARAGEIKGFTGIDsDyEKPEtPERVLKTNLSTVS |
| O95456 | T18 | Sugiyama | PSMG1 C21LRP DSCR2 PAC1 | ___MAAtFFGEVVKAPCRAGtEDEEEEEEGRREtPEDREVR |
| O95671 | S239 | Sugiyama | ASMTL | DLRRsVKHDsIPAADtFEDLsDVEGGGsEPTQRDAGsRDEK |
| O95747 | S339 | Sugiyama | OXSR1 KIAA1101 OSR1 | RRVPGssGRLHKtEDGGWEWsDDEFDEEsEEGKAAIsQLRs |
| O95786 | T770 | SIGNOR | RIGI DDX58 | KEQINMYKEKMMNDsILRLQtWDEAVFREKILHIQTHEKFI |
| O95816 | S73 | Sugiyama | BAG2 | KEILLEMIHSIQNSQDMRQIsDGEREELNLTANRLMGRTLT |
| O95831 | S116 | Sugiyama | AIFM1 AIF PDCD8 | NERIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLL |
| O95831 | S118 | Sugiyama | AIFM1 AIF PDCD8 | RIsGLGLtPEQKQKKAALsAsEGEEVPQDKAPSHVPFLLIG |
| P00338 | S310 | Sugiyama | LDHA PIG19 | SVPCILGQNGISDLVKVTLtsEEEARLKKsADtLWGIQKEL |
| P00338 | T220 | Sugiyama | LDHA PIG19 | VWSGMNVAGVSLKtLHPDLGtDKDKEQWKEVHKQVVEsAyE |
| P00338 | T309 | Sugiyama | LDHA PIG19 | LSVPCILGQNGISDLVKVTLtsEEEARLKKsADtLWGIQKE |
| P00736 | S206 | ELM | C1R | THSCQAECSSELYTEASGYIsSLEYPRSYPPDLRCNYSIRV |
| P01106 | T73 | iPTMNet | MYC BHLHE39 | SELQPPAPSEDIWKKFELLPtPPLsPsRRsGLCsPSyVAVT |
| P01375 | S2 | ELM | TNF TNFA TNFSF2 | ___________________MsTESMIRDVELAEEALPKKTG |
| P04004 | T69 | ELM | VTN | SCCTDYTAECKPQVTRGDVFtMPEDEYtVYDDGEEKNNATV |
| P04004 | T76 | ELM | VTN | AECKPQVTRGDVFtMPEDEYtVYDDGEEKNNATVHEQVGGP |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04198 | S261 | SIGNOR|ELM|iPTMNet | MYCN BHLHE37 NMYC | GRQTSGGDHKALSTSGEDTLsDsDDEDDEEEDEEEEIDVVT |
| P04198 | S263 | SIGNOR|ELM|iPTMNet | MYCN BHLHE37 NMYC | QTSGGDHKALSTSGEDTLsDsDDEDDEEEDEEEEIDVVTVE |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04818 | S124 | GPS6|PSP | TYMS TS OK/SW-cl.29 | KGVKIWDANGsRDFLDsLGFsTREEGDLGPVyGFQWRHFGA |
| P05187 | S192 | Sugiyama | ALPP PLAP | RVQHAsPAGtyAHtVNRNWysDADVPASARQEGCQDIATQL |
| P05198 | T279 | Sugiyama | EIF2S1 EIF2A | KEKIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAE |
| P05198 | T281 | Sugiyama | EIF2S1 EIF2A | KIEEKRGVFNVQMEPKVVtDtDEtELARQMERLERENAEVD |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05388 | S304 | Sugiyama | RPLP0 | AttAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| P05388 | S307 | Sugiyama | RPLP0 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| P05412 | S243 | ELM | JUN | QALKEEPQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNR |
| P05412 | S249 | ELM | JUN | PQtVPEMPGEtPPLsPIDMEsQERIKAERKRMRNRIAASKC |
| P05412 | T231 | ELM | JUN | LPQQMPVQHPRLQALKEEPQtVPEMPGEtPPLsPIDMEsQE |
| P05455 | S366 | ELM|Sugiyama | SSB | AQPGsGKGKVQFQGKKtKFAsDDEHDEHDENGAtGPVKRAR |
| P06127 | S482 | ELM | CD5 LEU1 | LSAyPALEGALHRSSMQPDNssDsDyDLHGAQRL_______ |
| P06127 | S483 | ELM | CD5 LEU1 | SAyPALEGALHRSSMQPDNssDsDyDLHGAQRL________ |
| P06127 | S485 | ELM | CD5 LEU1 | yPALEGALHRSSMQPDNssDsDyDLHGAQRL__________ |
| P06401 | S81 | ELM | PGR NR3C3 | PRPCQGQDPSDEKTQDQQSLsDVEGAYSRAEATRGAGGSSS |
| P06454 | T13 | ELM | PTMA TMSA | ________MsDAAVDtssEIttKDLKEKKEVVEEAENGRDA |
| P06454 | T14 | ELM | PTMA TMSA | _______MsDAAVDtssEIttKDLKEKKEVVEEAENGRDAP |
| P06454 | T8 | ELM | PTMA TMSA | _____________MsDAAVDtssEIttKDLKEKKEVVEEAE |
| P06493 | S39 | ELM | CDK1 CDC2 CDC28A CDKN1 P34CDC2 | yKGRHKTTGQVVAMKKIRLEsEEEGVPstAIREIsLLKELR |
| P06744 | S185 | ELM | GPI | LMVTEALKPYSsGGPRVWYVsNIDGTHIAKTLAQLNPESSL |
| P06748 | S125 | Sugiyama | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07237 | T85 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | KAAGKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFF |
| P07900 | S165 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPMGRGTK |
| P07900 | S231 | ELM|Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SQFIGyPITLFVEKERDKEVsDDEAEEKEDKEEEKEKEEKE |
| P07900 | S263 | ELM|Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EEKEKEEKEsEDKPEIEDVGsDEEEEKKDGDKKKKKKIKEK |
| P07900 | S391 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MDNCEELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P07900 | S470 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | HEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKH |
| P07900 | T467 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKEN |
| P07910 | S260 | SIGNOR|ELM|iPTMNet | HNRNPC HNRPC | ssVKKDETNVKMEsEGGADDsAEEGDLLDDDDNEDRGDDQL |
| P08047 | T579 | ELM | SP1 TSFP1 | GDHGAQLGLHGAGGDGIHDDtAGGEEGENSPDAQPQAGRRT |
| P08195 | S406 | Sugiyama | SLC3A2 MDU1 | QQILSLLESNKDLLLtssyLsDsGstGEHtKSLVTQYLNAT |
| P08238 | S160 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPIGRGTK |
| P08238 | S226 | ELM|Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sQFIGyPItLyLEKEREKEIsDDEAEEEKGEKEEEDKDDEE |
| P08238 | S255 | ELM|Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GEKEEEDKDDEEKPKIEDVGsDEEDDsGKDKKKKTKKIKEK |
| P08238 | S383 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MDSCDELIPEYLNFIRGVVDsEDLPLNIsREMLQQsKILKV |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T459 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEt |
| P08238 | Y457 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | LKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMK |
| P08575 | S1001 | SIGNOR | PTPRC CD45 | DYNRVPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINAS |
| P08575 | S1004 | SIGNOR | PTPRC CD45 | RVPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINASFIM |
| P08575 | S1005 | SIGNOR | PTPRC CD45 | VPLKHELEMSKESEHDsDEssDDDsDSEEPSKYINASFIMS |
| P08575 | S1009 | SIGNOR | PTPRC CD45 | HELEMSKESEHDsDEssDDDsDSEEPSKYINASFIMSYWKP |
| P09497 | S11 | SIGNOR|iPTMNet | CLTB | __________MADDFGFFSSsEsGAPEAAEEDPAAAFLAQQ |
| P09497 | S13 | SIGNOR|iPTMNet | CLTB | ________MADDFGFFSSsEsGAPEAAEEDPAAAFLAQQES |
| P09629 | S133 | ELM | HOXB7 HOX2C | QRDSDLAAESNFRIYPWMRssGTDRKRGRQTYTRYQTLELE |
| P09629 | T204 | ELM | HOXB7 HOX2C | WFQNRRMKWKKENKTAGPGttGQDRAEAEEEEEE_______ |
| P09960 | S236 | Sugiyama | LTA4H LTA4 | GPRTLVWSEKEQVEKSAyEFsETEsMLKIAEDLGGPYVWGQ |
| P0CAP2 | S364 | Sugiyama | POLR2M GRINL1A | NPEGESSGRYREVRDEDDDWssDEF________________ |
| P0DP23 | S102 | ELM | CALM1 CALM CAM CAM1 | sEEEIREAFRVFDKDGNGyIsAAELRHVMTNLGEKLtDEEV |
| P0DP23 | T80 | ELM | CALM1 CALM CAM CAM1 | GNGTIDFPEFLTMMARKMKDtDsEEEIREAFRVFDKDGNGy |
| P10242 | S11 | ELM | MYB | __________MARRPRHSIYssDEDDEDFEMCDHDYDGLLP |
| P10242 | S12 | ELM | MYB | _________MARRPRHSIYssDEDDEDFEMCDHDYDGLLPK |
| P10696 | S189 | Sugiyama | ALPG ALPPL ALPPL2 | RVQHASPAGAYAHTVNRNWysDADVPASARQEGCQDIATQL |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P10809 | S410 | Sugiyama | HSPD1 HSP60 | LNERLAKLsDGVAVLKVGGtsDVEVNEKKDRVtDALNAtRA |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P11388 | S1106 | Sugiyama | TOP2A TOP2 | PVKAWKEAQQKVPDEEENEEsDNEKEtEKsDsVTDSGPTFN |
| P11388 | S1377 | ELM|Sugiyama | TOP2A TOP2 | KtKTsPKLsNKELKPQKsVVsDLEADDVKGsVPLsssPPAt |
| P11388 | S1525 | ELM | TOP2A TOP2 | AVAPRAKSVRAKKPIKYLEEsDEDDLF______________ |
| P11388 | T1343 | ELM | TOP2A TOP2 | KTKFTMDLDsDEDFsDFDEKtDDEDFVPsDAsPPKtKTsPK |
| P11473 | S208 | ELM | VDR NR1I1 | DHCITSSDMMDSSSFSNLDLsEEDSDDPSVTLELSQLSMLP |
| P11586 | S318 | Sugiyama | MTHFD1 MTHFC MTHFD | FKPGKWMIQYNNLNLKTPVPsDIDIsRSCKPKPIGKLAREI |
| P11586 | T511 | Sugiyama | MTHFD1 MTHFC MTHFD | DIQIRRLKRLGIEKTDPTTLtDEEINRFARLDIDPEtITWQ |
| P11836 | S231 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | IVENEWKRTCSRPKsNIVLLsAEEKKEQTIEIKEEVVGLtE |
| P11836 | S289 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | EEEEEETETNFPEPPQDQESsPIENDSSP____________ |
| P11836 | T250 | SIGNOR|ELM|iPTMNet | MS4A1 CD20 | LsAEEKKEQTIEIKEEVVGLtEtssQPKNEEDIEIIPIQEE |
| P12259 | S692 | ELM | F5 | SKKLRLKFRDVKCIPDDDEDsyEIFEPPESTVMATRKMHDR |
| P12830 | S851 | ELM | CDH1 CDHE UVO | LVFDYEGsGsEAAsLSsLNssEsDKDQDYDYLNEWGNRFKK |
| P13349 | S133 | SIGNOR|ELM|iPTMNet | MYF5 BHLHC2 | NPNQRLPKVEILRNAIRYIEsLQELLREQVENYYSLPGQSC |
| P13349 | S49 | SIGNOR|ELM|iPTMNet | MYF5 BHLHC2 | GDEFVPRVAAFGAHKAELQGsDEDEHVRAPTGHHQAGHCLM |
| P13667 | S468 | Sugiyama | PDIA4 ERP70 ERP72 | ytFAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAM |
| P13667 | S470 | Sugiyama | PDIA4 ERP70 ERP72 | FAIADEEDyAGEVKDLGLsEsGEDVNAAILDEsGKKFAMEP |
| P13798 | S185 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | VAEKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQ |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P13798 | S8 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | _____________MERQVLLsEPEEAAALyRGLSRQPALsA |
| P13861 | S78 | Sugiyama | PRKAR2A PKR2 PRKAR2 | sLGHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRV |
| P13861 | S80 | Sugiyama | PRKAR2A PKR2 PRKAR2 | GHPPPEPGPDRVADAKGDsEsEEDEDLEVPVPsRFNRRVsV |
| P14598 | S208 | ELM | NCF1 NOXO2 SH3PXD1A | KSESGWWFCQMKAKRGWIPAsFLEPLDSPDETEDPEPNyAG |
| P14598 | S283 | ELM | NCF1 NOXO2 SH3PXD1A | WWVIRKDDVTGYFPSMyLQKsGQDVsQAQRQIKRGAPPRRs |
| P14598 | S348 | ELM | NCF1 NOXO2 SH3PXD1A | sVRFLQQRRRQARPGPQsPGsPLEEERQtQRsKPQPAVPPR |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | S306 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TETVEEPMEEEEAAKEEKEEsDDEAAVEEEEEEKKPKTKKV |
| P14625 | S439 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TDDFHDMMPKyLNFVKGVVDsDDLPLNVsREtLQQHKLLKV |
| P15531 | S120 | Sugiyama | NME1 NDPKA NM23 | KPGtIRGDFCIQVGRNIIHGsDsVEsAEKEIGLWFHPEELV |
| P17066 | T47 | Sugiyama | HSPA6 HSP70B' | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P17096 | S102 | SIGNOR|ELM|iPTMNet | HMGA1 HMGIY | KPRGRPKKLEKEEEEGIsQEssEEEQ_______________ |
| P17096 | S103 | SIGNOR|ELM|iPTMNet | HMGA1 HMGIY | PRGRPKKLEKEEEEGIsQEssEEEQ________________ |
| P17096 | S99 | SIGNOR|ELM|iPTMNet | HMGA1 HMGIY | PGRKPRGRPKKLEKEEEEGIsQEssEEEQ____________ |
| P17931 | S12 | iPTMNet | LGALS3 MAC2 | _________MADNFsLHDALsGSGNPNPQGWPGAWGNQPAG |
| P17931 | S6 | iPTMNet | LGALS3 MAC2 | _______________MADNFsLHDALsGSGNPNPQGWPGAW |
| P17936 | S138 | ELM | IGFBP3 IBP3 | SAVSRLRAYLLPAPPAPGNAsEsEEDRsAGsVEsPSVSsTH |
| P17936 | S140 | ELM | IGFBP3 IBP3 | VSRLRAYLLPAPPAPGNAsEsEEDRsAGsVEsPSVSsTHRV |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18031 | S352 | iPTMNet | PTPN1 PTP1B | QWVKEEtQEDKDCPIKEEKGsPLNAAPYGIEsMsQDtEVRS |
| P18031 | S378 | iPTMNet | PTPN1 PTP1B | PYGIEsMsQDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKD |
| P18031 | S386 | iPTMNet | PTPN1 PTP1B | QDtEVRSRVVGGsLRGAQAAsPAKGEPsLPEKDEDHALSYW |
| P18146 | S378 | ELM | EGR1 KROX24 ZNF225 | HIRIHTGQKPFQCRICMRNFsRSDHLTTHIRTHtGEKPFAC |
| P18846 | S36 | ELM | ATF1 | PGSAVQGAHISHIAQQVSSLsEsEEsQDsSDsIGssQKAHG |
| P18858 | S66 | ELM | LIG1 | VsEsDsPVKRPGRKAARVLGsEGEEEDEALsPAKGQKPALD |
| P18887 | S485 | PSP | XRCC1 | QEDIDIEGVQsEGQDNGAEDsGDtEDELRRVAEQKEHRLPP |
| P18887 | S518 | SIGNOR|iPTMNet|PSP | XRCC1 | QKEHRLPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPE |
| P18887 | T488 | PSP | XRCC1 | IDIEGVQsEGQDNGAEDsGDtEDELRRVAEQKEHRLPPGQE |
| P18887 | T519 | SIGNOR|iPTMNet|PSP | XRCC1 | KEHRLPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPEL |
| P18887 | T523 | SIGNOR|iPTMNet|PSP | XRCC1 | LPPGQEENGEDPyAGstDENtDsEEHQEPPDLPVPELPDFF |
| P19105 | T134 | Sugiyama | MYL12A MLCB MRLC3 RLC | TGTIQEDYLRELLttMGDRFtDEEVDELyREAPIDKKGNFN |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P19784 | S333 | Sugiyama | CSNK2A2 CK2A2 | RLTAKEAMEHPyFyPVVKEQsQPCADNAVLssGLtAAR___ |
| P19784 | S343 | Sugiyama | CSNK2A2 CK2A2 | PyFyPVVKEQsQPCADNAVLssGLtAAR_____________ |
| P19784 | S344 | Sugiyama | CSNK2A2 CK2A2 | yFyPVVKEQsQPCADNAVLssGLtAAR______________ |
| P19784 | T347 | Sugiyama | CSNK2A2 CK2A2 | PVVKEQsQPCADNAVLssGLtAAR_________________ |
| P20042 | S67 | Sugiyama | EIF2S2 EIF2B | EPtEDKDLEADEEDTRKKDAsDDLDDLNFFNQKKKKKKTKK |
| P21127 | S277 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| P21127 | S283 | Sugiyama | CDK11B CDC2L1 CDK11 PITSLREA PK58 | AQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSAESGSGS |
| P21291 | S192 | Sugiyama | CSRP1 CSRP CYRP | AKNFGPKGFGFGQGAGALVHsE___________________ |
| P21673 | S146 | SIGNOR|ELM|iPTMNet | SAT1 SAT | HFLVAEWNEPSINFYKRRGAsDLsSEEGWRLFKIDKEYLLK |
| P21673 | S149 | SIGNOR|ELM|iPTMNet | SAT1 SAT | VAEWNEPSINFYKRRGAsDLsSEEGWRLFKIDKEYLLKMAT |
| P21673 | T10 | ELM|iPTMNet | SAT1 SAT | ___________MAKFVIRPAtAADCSDILRLIKELAKYEYM |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22314 | S13 | ELM | UBA1 A1S9T UBE1 | ________MSSsPLSKKRRVsGPDPKPGsNCsPAQsVLsEV |
| P22314 | S46 | Sugiyama | UBA1 A1S9T UBE1 | AQsVLsEVPSVPTNGMAKNGsEADIDEGLysRQLyVLGHEA |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P24534 | S106 | SIGNOR|iPTMNet | EEF1B2 EEF1B EF1B | DttGsGAtDsKDDDDIDLFGsDDEEEsEEAKRLREERLAQY |
| P24534 | S112 | SIGNOR|iPTMNet | EEF1B2 EEF1B EF1B | AtDsKDDDDIDLFGsDDEEEsEEAKRLREERLAQYESKKAK |
| P25205 | S711 | Sugiyama | MCM3 | RRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEt |
| P25205 | T713 | Sugiyama | MCM3 | KTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEtKE |
| P25788 | S243 | ELM | PSMA3 HC8 PSC8 | GRHEIVPKDIREEAEKyAKEsLKEEDEsDDDNM________ |
| P25788 | S250 | ELM|Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P25963 | S283 | ELM | NFKBIA IKBA MAD3 NFKBI | TRIQQQLGQLTLENLQMLPEsEDEEsyDtEsEFTEFtEDEL |
| P25963 | S32 | ELM | NFKBIA IKBA MAD3 NFKBI | AMEGPRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEI |
| P25963 | S36 | ELM | NFKBIA IKBA MAD3 NFKBI | PRDGLKKERLLDDRHDsGLDsMKDEEyEQMVKELQEIRLEP |
| P25963 | T291 | ELM | NFKBIA IKBA MAD3 NFKBI | QLTLENLQMLPEsEDEEsyDtEsEFTEFtEDELPyDDCVFG |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26196 | S475 | Sugiyama | DDX6 HLR2 RCK | TEIKPIPsNIDKSLyVAEyHsEPVEDEKP____________ |
| P27348 | S37 | Sugiyama | YWHAQ | ERyDDMAtCMKAVtEQGAELsNEERNLLsVAyKNVVGGRRS |
| P27695 | S290 | ELM | APEX1 APE APE1 APEX APX HAP1 REF1 | MMNARSKNVGWRLDYFLLSHsLLPALCDSKIRSKALGSDHC |
| P27708 | S1069 | Sugiyama | CAD | FKFSRLLDTIGISQPQWRELsDLESARQFCQTVGYPCVVRP |
| P27824 | S554 | ELM|Sugiyama | CANX | EKDKGDEEEEGEEKLEEKQKsDAEEDGGtVsQEEEDRKPKA |
| P27824 | S564 | ELM|Sugiyama | CANX | GEEKLEEKQKsDAEEDGGtVsQEEEDRKPKAEEDEILNRsP |
| P29401 | S105 | Sugiyama | TKT | VWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGsL |
| P29401 | S449 | Sugiyama | TKT | MALEDLAMFRsVPtstVFyPsDGVAtEKAVELAANTKGICF |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P30305 | S186 | ELM | CDC25B CDC25HU2 | ItNsQAPDGRRKsEAGSGAAssSGEDKENDGFVFKMPWKPT |
| P30305 | S187 | ELM | CDC25B CDC25HU2 | tNsQAPDGRRKsEAGSGAAssSGEDKENDGFVFKMPWKPTH |
| P30533 | S247 | Sugiyama | LRPAP1 A2MRAP | KLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSA |
| P30533 | T248 | Sugiyama | LRPAP1 A2MRAP | LRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWDLAQSAN |
| P31327 | T1022 | Sugiyama | CPS1 | TLRQLGKKTVVVNCNPETVstDFDECDKLyFEELSLERILD |
| P32004 | S1181 | ELM | L1CAM CAML1 MIC5 | VDsEARPMKDEtFGEyRsLEsDNEEKAFGssQPsLNGDIKP |
| P32121 | T382 | SIGNOR|ELM|iPTMNet | ARRB2 ARB2 ARR2 | APETDVPVDTNLIEFDTNYAtDDDIVFEDFARLRLKGMKDD |
| P34897 | S52 | Sugiyama | SHMT2 | AQTQTGEANRGWtGQEsLsDsDPEMWELLQREKDRQCRGLE |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P34932 | S415 | Sugiyama | HSPA4 APG2 HSPH2 | TDVVPYPISLRWNsPAEEGssDCEVFSKNHAAPFSKVLTFy |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35222 | S29 | SIGNOR|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | ELDMAMEPDRKAAVsHWQQQsyLDsGIHsGATtTAPsLsGK |
| P35222 | T102 | SIGNOR|ELM|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | IDGQyAMTRAQRVRAAMFPEtLDEGMQIPStQFDAAHPtNV |
| P35222 | T112 | SIGNOR|ELM|PSP | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | QRVRAAMFPEtLDEGMQIPStQFDAAHPtNVQRLAEPSQML |
| P35222 | T393 | ELM | CTNNB1 CTNNB OK/SW-cl.35 PRO2286 | PsQRLVQNCLWtLRNLSDAAtKQEGMEGLLGTLVQLLGSDD |
| P35244 | S44 | Sugiyama | RPA3 REPA3 RPA14 | PVCFVGRLEKIHPTGKMFILsDGEGKNGTIELMEPLDEEIS |
| P35568 | S24 | ELM | IRS1 | PPEsDGFSDVRKVGYLRKPKsMHKRFFVLRAAsEAGGPARL |
| P35579 | S1943 | Sugiyama | MYH9 | RGDLPFVVPRRMARKGAGDGsDEEVDGKADGAEAKPAE___ |
| P35638 | S14 | ELM | DDIT3 CHOP CHOP10 GADD153 | _______MAAESLPFSFGTLssWELEAWYEDLQEVLssDEN |
| P35638 | S15 | ELM | DDIT3 CHOP CHOP10 GADD153 | ______MAAESLPFSFGTLssWELEAWYEDLQEVLssDENG |
| P35638 | S30 | ELM | DDIT3 CHOP CHOP10 GADD153 | FGTLssWELEAWYEDLQEVLssDENGGTYVSPPGNEEEESK |
| P35638 | S31 | ELM | DDIT3 CHOP CHOP10 GADD153 | GTLssWELEAWYEDLQEVLssDENGGTYVSPPGNEEEESKI |
| P35659 | S306 | Sugiyama | DEK | DSSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPTDEELK |
| P35659 | S307 | Sugiyama | DEK | SSTTKKNQNSSKKEsEsEDssDDEPLIKKLKKPPTDEELKE |
| P36578 | T62 | Sugiyama | RPL4 RPL1 | TNLRKNNRQPyAVsELAGHQtsAEsWGtGRAVARIPRVRGG |
| P36915 | S51 | Sugiyama | GNL1 HSR1 | RsssNsRSGSRERREEQtDtsDGEsVTHHIRRLNQQPsQGL |
| P36915 | T48 | Sugiyama | GNL1 HSR1 | DGLRsssNsRSGSRERREEQtDtsDGEsVTHHIRRLNQQPs |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37840 | S129 | iPTMNet | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P39023 | T305 | Sugiyama | RPL3 OK/SW-cl.32 | YKIGQGyLIKDGKLIKNNAstDyDLSDKSINPLGGFVHYGE |
| P39687 | S158 | ELM | ANP32A C15orf1 LANP MAPM PHAP1 | LLPQLtyLDGyDRDDKEAPDsDAEGYVEGLDDEEEDEDEEE |
| P39687 | S204 | ELM | ANP32A C15orf1 LANP MAPM PHAP1 | QVVEDEEDEDEEEEGEEEDVsGEEEEDEEGYNDGEVDDEED |
| P41236 | S121 | SIGNOR|ELM|iPTMNet|Sugiyama | PPP1R2 IPP2 | ARKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFE |
| P41236 | S122 | SIGNOR|ELM|iPTMNet | PPP1R2 IPP2 | RKLAAAEGLEPKyRIQEQEssGEEDsDLsPEEREKKRQFEM |
| P41236 | S87 | SIGNOR|ELM|iPTMNet | PPP1R2 IPP2 | KIDEPstPYHsMMGDDEDACsDtEAtEAMAPDILARKLAAA |
| P42166 | S66 | Sugiyama | TMPO LAP2 | TARNRPPLPAGTNsKGPPDFssDEEREPtPVLGsGAAAAGR |
| P42166 | S67 | Sugiyama | TMPO LAP2 | ARNRPPLPAGTNsKGPPDFssDEEREPtPVLGsGAAAAGRS |
| P42166 | T74 | Sugiyama | TMPO LAP2 | PAGTNsKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P42167 | S66 | Sugiyama | TMPO LAP2 | TARNRPPLPAGTNSKGPPDFssDEEREPtPVLGsGAAAAGR |
| P42167 | S67 | Sugiyama | TMPO LAP2 | ARNRPPLPAGTNSKGPPDFssDEEREPtPVLGsGAAAAGRS |
| P42167 | T74 | Sugiyama | TMPO LAP2 | PAGTNSKGPPDFssDEEREPtPVLGsGAAAAGRSRAAVGRK |
| P42574 | S176 | Sugiyama | CASP3 CPP32 | KLFIIQACRGTELDCGIEtDsGVDDDMACHKIPVEADFLYA |
| P42574 | T174 | Sugiyama | CASP3 CPP32 | KPKLFIIQACRGTELDCGIEtDsGVDDDMACHKIPVEADFL |
| P42768 | S483 | SIGNOR|iPTMNet | WAS IMD2 | SEGLVGALMHVMQKRSRAIHssDEGEDQAGDEDEDDEWDD_ |
| P42768 | S484 | SIGNOR|iPTMNet | WAS IMD2 | EGLVGALMHVMQKRSRAIHssDEGEDQAGDEDEDDEWDD__ |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P45973 | S14 | Sugiyama | CBX5 HP1A | _______MGKKTKRtADssssEDEEEyVVEKVLDRRVVKGQ |
| P46777 | S185 | Sugiyama | RPL5 MSTP030 | GAVDGGLsIPHstKRFPGyDsEsKEFNAEVHRKHIMGQNVA |
| P46777 | S187 | Sugiyama | RPL5 MSTP030 | VDGGLsIPHstKRFPGyDsEsKEFNAEVHRKHIMGQNVADy |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P47712 | S437 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | MEEELENIttKHIVsNDssDsDDEsHEPKGtENEDAGsDyQ |
| P48506 | S291 | Sugiyama | GCLC GLCL GLCLC | TICPIVMALSAASPFYRGYVsDIDCRWGVISASVDDRTREE |
| P48741 | T47 | Sugiyama | HSPA7 HSP70B | RVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAALNPHN |
| P49368 | T254 | Sugiyama | CCT3 CCTG TRIC5 | KNPRIVLLDssLEyKKGEsQtDIEITREEDFTRILQMEEEY |
| P49427 | S203 | ELM | CDC34 UBCH3 UBE2R1 | VPTTLAEYCVKTKAPAPDEGsDLFYDDYYEDGEVEEEADsC |
| P49427 | S222 | ELM | CDC34 UBCH3 UBE2R1 | GsDLFYDDYYEDGEVEEEADsCFGDDEDDsGtEEs______ |
| P49427 | S231 | ELM | CDC34 UBCH3 UBE2R1 | YEDGEVEEEADsCFGDDEDDsGtEEs_______________ |
| P49427 | S236 | ELM | CDC34 UBCH3 UBE2R1 | VEEEADsCFGDDEDDsGtEEs____________________ |
| P49427 | T233 | ELM | CDC34 UBCH3 UBE2R1 | DGEVEEEADsCFGDDEDDsGtEEs_________________ |
| P49736 | S139 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | QRDREAGRGLGRMRRGLLyDsDEEDEERPARKRRQVERAtE |
| P49736 | T457 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | TVILANHVAKKDNKVAVGELtDEDVKMITSLSKDQQIGEKI |
| P49795 | S151 | ELM | RGS19 GAIP GNAI3IP | NQHVVDEKARLIyEDyVSILsPKEVSLDSRVREGINKKMQE |
| P49795 | S24 | SIGNOR|ELM|iPTMNet | RGS19 GAIP GNAI3IP | PHEAEKQITGPEEADRPPsMssHDTASPAAPSRNPCCLCWC |
| P49810 | S19 | ELM | PSEN2 AD4 PS2 PSNL2 STM2 | __MLTFMAsDsEEEVCDERtsLMsAEsPtPRSCQEGRQGPE |
| P49810 | S335 | ELM | PSEN2 AD4 PS2 PSNL2 STM2 | LQLPYDPEMEEDsYDsFGEPsYPEVFEPPLTGYPGEELEEE |
| P49810 | S7 | ELM | PSEN2 AD4 PS2 PSNL2 STM2 | ______________MLTFMAsDsEEEVCDERtsLMsAEsPt |
| P49810 | S9 | ELM | PSEN2 AD4 PS2 PSNL2 STM2 | ____________MLTFMAsDsEEEVCDERtsLMsAEsPtPR |
| P50502 | S76 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KEEKPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAP |
| P50502 | S79 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAPQEM |
| P51116 | S410 | Sugiyama | FXR2 FMR1L2 | LGFRPPGsGRGsGGsDKAGystDEssSSsLHATRTYGGSYG |
| P51116 | T411 | Sugiyama | FXR2 FMR1L2 | GFRPPGsGRGsGGsDKAGystDEssSSsLHATRTYGGSYGG |
| P51580 | S14 | Sugiyama | TPMT | _______MDGTRTSLDIEEysDtEVQKNQVLTLEEWQDKWV |
| P51811 | S383 | ELM | XK XKR1 XRG1 | ILFMLVFYQFFHPCKKLFSSsVSEGFQRWLRCFCWACRQQK |
| P51858 | S132 | Sugiyama | HDGF HMG1L2 | PEPEPEAAEGDGDKKGNAEGssDEEGKLVIDEPAKEKNEKG |
| P51858 | S133 | Sugiyama | HDGF HMG1L2 | EPEPEAAEGDGDKKGNAEGssDEEGKLVIDEPAKEKNEKGA |
| P51946 | T315 | ELM|PSP|Sugiyama | CCNH | KGYEDDDYVsKKSKHEEEEWtDDDLVEsL____________ |
| P52655 | S280 | SIGNOR|ELM | GTF2A1 TF2A1 | AQPAQTQAPLVLQVDGTGDTssEEDEDEEEDYDDDEEEDKE |
| P52655 | S281 | SIGNOR|ELM | GTF2A1 TF2A1 | QPAQTQAPLVLQVDGTGDTssEEDEDEEEDYDDDEEEDKEK |
| P52655 | S316 | SIGNOR|ELM | GTF2A1 TF2A1 | EEDKEKDGAEDGQVEEEPLNsEDDVsDEEGQELFDTENVVV |
| P52655 | S321 | SIGNOR|ELM | GTF2A1 TF2A1 | KDGAEDGQVEEEPLNsEDDVsDEEGQELFDTENVVVCQYDK |
| P52789 | S340 | Sugiyama | HK2 | FGGKLSPELLNTGRFETKDIsDIEGEKDGIRKAREVLMRLG |
| P53999 | S11 | ELM | SUB1 PC4 RPO2TC1 | __________MPKSKELVsssssGsDsDsEVDKKLKRKKQV |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S13 | ELM | SUB1 PC4 RPO2TC1 | ________MPKSKELVsssssGsDsDsEVDKKLKRKKQVAP |
| P53999 | S15 | ELM|Sugiyama | SUB1 PC4 RPO2TC1 | ______MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEK |
| P53999 | S17 | ELM|Sugiyama | SUB1 PC4 RPO2TC1 | ____MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPV |
| P53999 | S19 | ELM | SUB1 PC4 RPO2TC1 | __MPKSKELVsssssGsDsDsEVDKKLKRKKQVAPEKPVKK |
| P54105 | S102 | Sugiyama | CLNS1A CLCI ICLN | VNAKFEEEsKEPVADEEEEDsDDDVEPITEFRFVPSDKSAL |
| P54278 | S547 | Sugiyama | PMS2 PMSL2 | RGSQEHVDsQEKAPKTDDSFsDVDCHSNQEDTGCKFRVLPQ |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55042 | S214 | ELM | RRAD RAD | DDVPIILVGNKSDLVRSREVsVDEGRACAVVFDCKFIETSA |
| P55060 | S377 | Sugiyama | CSE1L CAS XPO2 | ADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDLVRGLCKFF |
| P55060 | T255 | Sugiyama | CSE1L CAS XPO2 | METWMNNFHTLLTLDNKLLQtDDEEEAGLLELLKSQICDNA |
| P55081 | S116 | Sugiyama | MFAP1 | DVEERLARHRKIVEPEVVGEsDsEVEGDAWRMEREDssEEE |
| P55081 | S118 | Sugiyama | MFAP1 | EERLARHRKIVEPEVVGEsDsEVEGDAWRMEREDssEEEEE |
| P55081 | S132 | Sugiyama | MFAP1 | VVGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMM |
| P55081 | S133 | Sugiyama | MFAP1 | VGEsDsEVEGDAWRMEREDssEEEEEEIDDEEIERRRGMMR |
| P55081 | T267 | Sugiyama | MFAP1 | ETKKELEENKRsLAALDALNtDDENDEEEyEAWKVRELKRI |
| P55087 | S276 | SIGNOR|ELM | AQP4 | VEFKRRFKEAFSKAAQQTKGsYMEVEDNRsQVETDDLILKP |
| P55087 | S285 | SIGNOR|ELM | AQP4 | AFSKAAQQTKGsYMEVEDNRsQVETDDLILKPGVVHVIDVD |
| P55087 | S316 | SIGNOR|ELM | AQP4 | PGVVHVIDVDRGEEKKGKDQsGEVLssV_____________ |
| P55957 | S64 | SIGNOR|ELM|iPTMNet | BID | LPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQEDIIR |
| P55957 | T59 | SIGNOR|ELM|iPTMNet | BID | ALGHELPVLAPQWEGyDELQtDGNRssHsRLGRIEADsEsQ |
| P56270 | S469 | ELM | MAZ ZNF801 | VAAPPTAVGSLsGAEGVPVSsQPLPSQPW____________ |
| P60484 | S370 | SIGNOR|iPTMNet | PTEN MMAC1 TEP1 | TVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDttDsDPENE |
| P60484 | S385 | SIGNOR|ELM | PTEN MMAC1 TEP1 | VtPDVsDNEPDHyRYsDttDsDPENEPFDEDQHtQItKV__ |
| P60484 | T366 | SIGNOR|iPTMNet | PTEN MMAC1 TEP1 | YFTKTVEEPSNPEASSsTSVtPDVsDNEPDHyRYsDttDsD |
| P61201 | S178 | Sugiyama | COPS2 CSN2 TRIP15 | LYLEREEYGKLQKILRQLHQsCQTDDGEDDLKKGTQLLEIY |
| P61218 | S2 | ELM | POLR2F POLRF | ___________________MsDNEDNFDGDDFDDVEEDEGL |
| P61244 | S11 | ELM | MAX BHLHD4 | __________MsDNDDIEVEsDEEQPRFQSAADKRAHHNAL |
| P61244 | S2 | ELM | MAX BHLHD4 | ___________________MsDNDDIEVEsDEEQPRFQSAA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S263 | Sugiyama | RPS3A FTE1 MFTL | GDEtGAKVERADGyEPPVQEsV___________________ |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62269 | T60 | Sugiyama | RPS18 D6S218E | YAHVVLRKADIDLTKRAGELtEDEVERVItIMQNPRQYKIP |
| P62633 | S121 | Sugiyama | CNBP RNF163 ZNF9 | CGKPGHLARDCDHADEQKCysCGEFGHIQKDCTKVKCYRCG |
| P63104 | S37 | Sugiyama | YWHAZ | ERyDDMAACMKsVtEQGAELsNEERNLLsVAyKNVVGARRs |
| P67870 | S2 | ELM|PSP | CSNK2B CK2N G5A | ___________________MsssEEVSWISWFCGLRGNEFF |
| P67870 | S3 | ELM|PSP | CSNK2B CK2N G5A | __________________MsssEEVSWISWFCGLRGNEFFC |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P84090 | S24 | iPTMNet | ERH | TILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEEHLKRMN |
| P84090 | T18 | iPTMNet | ERH | ___MsHTILLVQPTKRPEGRtyADyEsVNECMEGVCKMYEE |
| Q00341 | S31 | Sugiyama | HDLBP HBP VGL | sFAEHRSGLVPQQIKVAtLNsEEEsDPPtyKDAFPPLPEKA |
| Q00613 | T142 | SIGNOR|ELM|PSP | HSF1 HSTF1 | VSTLKSEDIKIRQDSVTKLLtDVQLMKGKQECMDSKLLAMK |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01892 | S129 | SIGNOR|ELM|iPTMNet | SPIB | NFASQTLVPPAYAPYPSPVLsEEEDLPLDSPALEVsDsESD |
| Q01892 | S144 | SIGNOR|ELM|iPTMNet | SPIB | PSPVLsEEEDLPLDSPALEVsDsESDEALVAGPEGKGSEAG |
| Q01892 | S146 | SIGNOR|ELM|iPTMNet | SPIB | PVLsEEEDLPLDSPALEVsDsESDEALVAGPEGKGSEAGTR |
| Q01892 | S37 | SIGNOR|ELM|iPTMNet | SPIB | LYPDGVFYDLDSCKHSSYPDsEGAPDSLWDWTVAPPVPAtP |
| Q02790 | T436 | Sugiyama | FKBP4 FKBP52 | ERLAEEENKAKAEAssGDHPtDTEMKEEQKsNtAGsQsQVE |
| Q02878 | T235 | Sugiyama | RPL6 TXREB1 | AyFKKKKLRKPRHQEGEIFDtEKEKYEITEQRKIDQKAVDs |
| Q02880 | S1522 | Sugiyama | TOP2B | DTVPKPKRAPKQKKVVEAVNsDsDsEFGIPKKTTtPKGKGR |
| Q02880 | S1524 | Sugiyama | TOP2B | VPKPKRAPKQKKVVEAVNsDsDsEFGIPKKTTtPKGKGRGA |
| Q02952 | S598 | Sugiyama | AKAP12 AKAP250 | CLEKGLAEVQQDGEAEEGAtsDGEKKREGVtPWAsFKKMVt |
| Q03135 | S88 | SIGNOR|ELM|iPTMNet | CAV1 CAV | FEDVIAEPEGTHsFDGIWKAsFTTFTVTKYWFYRLLSALFG |
| Q04206 | S529 | ELM | RELA NFKB3 | RPPDPAPAPLGAPGLPNGLLsGDEDFSsIADMDFsALLSQI |
| Q04637 | S1430 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GQDIGAFVAEQKVEyTLGEEsEAPGQRALPsEELNRQLEKL |
| Q05519 | S434 | Sugiyama | SRSF11 SFRS11 | sDKDVKQVtRDyDEEEQGYDsEKEKKEEKKPIEtGsPKtKE |
| Q05940 | S511 | SIGNOR|ELM|iPTMNet | SLC18A2 SVMT VMAT2 | KTKMYTQNNIQSYPIGEDEEsEsD_________________ |
| Q05940 | S513 | SIGNOR|ELM | SLC18A2 SVMT VMAT2 | KMYTQNNIQSYPIGEDEEsEsD___________________ |
| Q06413 | S59 | ELM | MEF2C | CDCEIALIIFNSTNKLFQYAsTDMDKVLLKYTEYNEPHESR |
| Q07020 | T87 | Sugiyama | RPL18 | IRKMKLPGRENKtAVVVGtItDDVRVQEVPKLKVCALRVTS |
| Q07021 | S213 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | VGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDSLDW |
| Q07954 | S3642 | Sugiyama | LRP1 A2MR APR | SGHCIPLRWRCDADADCMDGsDEEACGTGVRTCPLDEFQCN |
| Q08945 | S444 | Sugiyama | SSRP1 FACT80 | NIKNRGLKEGMNPsyDEyADsDEDQHDAYLERMKEEGKIRE |
| Q08AD1 | S1148 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | LSDLKPPEKADVPVEKYDGEsDKEQFDDDQKVCCGFFFKDD |
| Q12874 | T131 | Sugiyama | SF3A3 SAP61 | EELLKARENPSEEAQNLVEFtDEEGyGRYLDLHDCYLKYIN |
| Q12972 | S204 | SIGNOR|ELM | PPP1R8 ARD1 NIPP1 | EGNLDIQRPKRKRKNsRVtFsEDDEIINPEDVDPSVGRFRN |
| Q12972 | T161 | SIGNOR|ELM | PPP1R8 ARD1 NIPP1 | EKMGGEDDELKGLLGLPEEEtELDNLTEFNTAHNKRIsTLT |
| Q13017 | T1217 | Sugiyama | ARHGAP5 RHOGAP5 | EDPLLsPVETWKGGIDNPAItsDQELDDKKMKKKTHKVKED |
| Q13033 | T293 | Sugiyama | STRN3 GS2NA SG2NA | KDKHRMNKHKIGNEGLAADLtDDPDtEEALKEFDFLVTAED |
| Q13085 | S29 | SIGNOR|ELM | ACACA ACAC ACC1 ACCA | QPLELNQHSRFIIGsVsEDNsEDEISNLVKLDLLEEKEGsL |
| Q13144 | S717 | SIGNOR|iPTMNet | EIF2B5 EIF2BE | LRKNQQLQRFIQWLKEAEEEssEDD________________ |
| Q13144 | S718 | SIGNOR|iPTMNet | EIF2B5 EIF2BE | RKNQQLQRFIQWLKEAEEEssEDD_________________ |
| Q13164 | S562 | Sugiyama | MAPK7 BMK1 ERK5 PRKM7 | ERGAGASGGPStDPLAGLVLsDNDRsLLERWTRMARPAAPA |
| Q13347 | S302 | Sugiyama | EIF3I EIF3S2 TRIP1 | KGHFGPINSVAFHPDGKSYssGGEDGyVRIHYFDPQYFEFE |
| Q13351 | T23 | SIGNOR|ELM | KLF1 EKLF | TAETALPSISTLTALGPFPDtQDDFLKWWRSEEAQDMGPGP |
| Q13409 | S51 | Sugiyama | DYNC1I2 DNCI2 DNCIC2 | ERKKKETDQKKEAVAPVQEEsDLEKKRREAEALLQSMGLTP |
| Q13428 | S347 | Sugiyama | TCOF1 | AsQTKAGKPEEDSEsSSEEssDsEEETPAAKALLQAKASGK |
| Q13428 | S417 | Sugiyama | TCOF1 | AVAKAQAGKREEDSQSSSEEsDsEEEAPAQAKPSGKAPQVR |
| Q13428 | S87 | Sugiyama | TCOF1 | EDAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRLAs |
| Q13428 | S88 | Sugiyama | TCOF1 | DAALQAKKTRVsDPIstsEssEEEEEAEAETAKAtPRLAst |
| Q13435 | S302 | Sugiyama | SF3B2 SAP145 | SRQEEMNsQQEEEEMETDARssLGQsAsEtEEDtVsVsKKE |
| Q13435 | S303 | Sugiyama | SF3B2 SAP145 | RQEEMNsQQEEEEMETDARssLGQsAsEtEEDtVsVsKKEK |
| Q13435 | S309 | Sugiyama | SF3B2 SAP145 | sQQEEEEMETDARssLGQsAsEtEEDtVsVsKKEKNRKRRN |
| Q13435 | T311 | Sugiyama | SF3B2 SAP145 | QEEEEMETDARssLGQsAsEtEEDtVsVsKKEKNRKRRNRK |
| Q13442 | S60 | Sugiyama | PDAP1 HASPP28 | QKEGGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGL |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13541 | S112 | SIGNOR|iPTMNet|Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13547 | S421 | SIGNOR|ELM|iPTMNet|Sugiyama | HDAC1 RPD3L1 | PDKRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAK |
| Q13547 | S423 | SIGNOR|ELM|iPTMNet|Sugiyama | HDAC1 RPD3L1 | KRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAKRV |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13610 | S50 | Sugiyama | PWP1 | EEVKRLIAEAKEKLQEEGGGsDEEEtGsPsEDGMQsARTQA |
| Q13769 | S312 | Sugiyama | THOC5 C22orf19 KIAA0983 | GSVDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQ |
| Q13769 | S314 | Sugiyama | THOC5 C22orf19 KIAA0983 | VDEAKALFKPPEDsQDDEsDsDAEEEQttKRRRPtLGVQLD |
| Q13895 | S98 | Sugiyama | BYSL ENP1 | KPAAPRERTTRLGPRMPQDGsDDEDEEWPTLEKAATMTAAG |
| Q14005 | S743 | SIGNOR|iPTMNet | IL16 | NLFSPIMSENHGHMPLQPNAsLNEEEGTQGHPDGtPPKLDT |
| Q14204 | S1313 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | DREKCAKAKEALELtDtGLLsGSEERVQVALEELQDLKGVW |
| Q14432 | S408 | Sugiyama | PDE3A | QAIHKPRVNPVtsLsENytCsDsEESSEKDKLAIPKRLRRs |
| Q14566 | S758 | Sugiyama | MCM6 | EDESALKRSELVNWYLKEIEsEIDsEEELINKKRIIEKVIH |
| Q14566 | S762 | Sugiyama | MCM6 | ALKRSELVNWYLKEIEsEIDsEEELINKKRIIEKVIHRLTH |
| Q14568 | S165 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | AEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERMGRGTK |
| Q14676 | S168 | Sugiyama | MDC1 KIAA0170 NFBD1 | EEtPRVQGEtQPQRLLLAEDsEEEVDFLsERRMVKKSRTTS |
| Q14676 | T455 | Sugiyama | MDC1 KIAA0170 NFBD1 | MPQRVVLLQRsQtttERDsDtDVEEEELPVENREAVLKDHT |
| Q14684 | S245 | Sugiyama | RRP1B KIAA0179 | PFVPEETMEEQKtKVGDGDLsAEEIPENEVsLRRAVSKKKT |
| Q14684 | T451 | Sugiyama | RRP1B KIAA0179 | PEASGLKALKARVAEPGAEAtsstGEEsGsEHPPAVPMHNK |
| Q14694 | S576 | Sugiyama | USP10 KIAA0190 | sNGPKNHSVNEEEQEEQGEGsEDEWEQVGPRNKTSVTRQAD |
| Q15019 | S218 | Sugiyama | SEPTIN2 DIFF6 KIAA0158 NEDD5 SEPT2 | RILDEIEEHNIKIyHLPDAEsDEDEDFKEQtRLLKASIPFS |
| Q15022 | S583 | SIGNOR | SUZ12 CHET9 JJAZ1 KIAA0160 | RLYFHsDtCLPLRPQEMEVDsEDEKDPEWLREKTITQIEEF |
| Q15084 | S428 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15185 | S113 | Sugiyama | PTGES3 P23 TEBP | RAKLNWLsVDFNNWKDWEDDsDEDMsNFDRFSEMMNNMGGD |
| Q15293 | T100 | Sugiyama | RCN1 RCN | sKERLGKIVDRIDNDGDGFVttEELKtWIKRVQKRyIFDNV |
| Q15459 | S451 | Sugiyama | SF3A1 SAP114 | IGLLDPRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAE |
| Q15751 | S1521 | Sugiyama | HERC1 | tsPNYRLIKsRsEsDLsQPEsDEEGYALsGRRNVDLDLAAs |
| Q15785 | S45 | Sugiyama | TOMM34 URCC3 | yAEASALyGRALRVLQAQGssDPEEEsVLysNRAACHLKDG |
| Q15906 | S41 | ELM | VPS72 TCFL1 YL1 | LEAEEEDEFYQTTYGGFTEEsGDDEYQGDQsDTEDEVDsDF |
| Q15906 | S51 | ELM | VPS72 TCFL1 YL1 | QTTYGGFTEEsGDDEYQGDQsDTEDEVDsDFDIDEGDEPSs |
| Q15906 | S59 | ELM | VPS72 TCFL1 YL1 | EEsGDDEYQGDQsDTEDEVDsDFDIDEGDEPSsDGEAEEPR |
| Q15906 | S71 | ELM | VPS72 TCFL1 YL1 | sDTEDEVDsDFDIDEGDEPSsDGEAEEPRRKRRVVtKAYKE |
| Q16543 | S13 | SIGNOR|ELM|iPTMNet|PSP | CDC37 CDC37A | ________MVDysVWDHIEVsDDEDEtHPNIDTASLFRWRH |
| Q16623 | S14 | SIGNOR|ELM|iPTMNet | STX1A STX1 | _______MKDRTQELRtAKDsDDDDDVAVTVDRDRFMDEFF |
| Q16625 | S408 | ELM | OCLN | GRSKRTEQDHyEtDyttGGEsCDELEEDWIREYPPItSDQQ |
| Q16625 | T404 | ELM | OCLN | KGRAGRSKRTEQDHyEtDyttGGEsCDELEEDWIREYPPIt |
| Q16666 | S132 | ELM | IFI16 IFNGIP1 | sstVKtEGAEAtPGAQKRKKsTKEKAGPKGsKVsEEQtQPP |
| Q2T9J0 | S171 | Sugiyama | TYSND1 | FGDEAAEQWRFSSAARDDEVsEDEEADQLRALGWFALLGVR |
| Q32P28 | S479 | Sugiyama | P3H1 GROS1 LEPRE1 PSEC0109 | LTMNSKLLNGSQRVVMDGVIsDHECQELQRLTNVAATSGDG |
| Q4G0J3 | S261 | Sugiyama | LARP7 HDCMA18P | MDtsNtsIsKMKRsRPtsEGsDIEstEPQKQCSKKKKKRDR |
| Q53EL6 | S345 | Sugiyama | PDCD4 H731 | NHLVKEIDMLLKEyLLSGDIsEAEHCLKELEVPHFHHELVY |
| Q53EL6 | S80 | Sugiyama | PDCD4 H731 | KRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPKGRLL |
| Q56P03 | S109 | Sugiyama | EAPP C14orf11 BM-036 | sGNGKVATAPTRyYDDIyFDsDsEDEDRAVQVtKKKKKKQH |
| Q56P03 | S111 | Sugiyama | EAPP C14orf11 BM-036 | NGKVATAPTRyYDDIyFDsDsEDEDRAVQVtKKKKKKQHKI |
| Q58FF7 | S205 | Sugiyama | HSP90AB3P HSP90BC | sQFIGyPItLyLEKEQDKEIsDDEAEEEKGEKEEEDKDDEE |
| Q58FF8 | S177 | Sugiyama | HSP90AB2P HSP90BB | GEKEEENKDDEEKPKIEDVGsDEEDDsGKDKKKKTKKIKEK |
| Q5H9R7 | S617 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | NIALFEACCKERIQQFDDGGsDEEDIWEEKHIAFtPEsQRR |
| Q5JSH3 | S403 | Sugiyama | WDR44 RPH11 | PLTLHIMRRtKEyVsNDAAQsDDEEKLQsQPTDTDGGRLKQ |
| Q5M775 | S241 | Sugiyama | SPECC1 CYTSB NSP5 | DTEPMIRALEEKNKNFQKELsDLEEENRVLKEKLIYLEHSP |
| Q5T1M5 | S1164 | Sugiyama | FKBP15 KIAA0674 | GstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRPKA |
| Q5VT52 | S374 | Sugiyama | RPRD2 KIAA0460 HSPC099 | EKsAtPEPVtDNRDVEDMELsDVEDDGsKIIVEDRKEKPAE |
| Q5VZL5 | S122 | Sugiyama | ZMYM4 KIAA0425 ZNF262 | VssIHtDDsLEVERRVtQHEsDNENEIQIQNKLKKDFPKQF |
| Q5VZL5 | T118 | Sugiyama | ZMYM4 KIAA0425 ZNF262 | KDNLVssIHtDDsLEVERRVtQHEsDNENEIQIQNKLKKDF |
| Q68D20 | S161 | Sugiyama | PMS2CL PMS2P13 | RGSQEHVDsQEKAPEtDDsFsDVDCHSNQEDTGCKFQVLPQ |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6NZY4 | T342 | Sugiyama | ZCCHC8 | WLKEAELENsGLALYDGKDGtDGEtEVGEIQQNKSVTYDLS |
| Q6PD62 | T925 | Sugiyama | CTR9 KIAA0155 SH2BP1 | GGGGRRSKKGGEFDEFVNDDtDDDLPIsKKKKRRKGsGsEQ |
| Q6PKG0 | S627 | Sugiyama | LARP1 KIAA0731 LARP | FLFDEEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVt |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | Y633 | Sugiyama | LARP1 KIAA0731 LARP | MEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPHyM |
| Q6VY07 | S278 | ELM | PACS1 KIAA1175 | IDHEGIKSKLSDRSPDIDNYsEEEEESFSSEQEGSDDPLHG |
| Q712K3 | S233 | SIGNOR|iPTMNet | UBE2R2 CDC34B UBC3B | DDIDDEDEEEEDADCYDDDDsGNEES_______________ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q76FK4 | S838 | Sugiyama | NOL8 C9orf34 NOP132 | PGEEWVKESMGKTSGKLFDssDDDEsDsEDDSNRFKIKPQF |
| Q76FK4 | S843 | Sugiyama | NOL8 C9orf34 NOP132 | VKESMGKTSGKLFDssDDDEsDsEDDSNRFKIKPQFEGRAG |
| Q7Z4V5 | S366 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKEEKERRRERADRGEAERGsGGssGDELREDDEPVKKRGR |
| Q7Z4V5 | S369 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EKERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGR |
| Q7Z4V5 | S370 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGRG |
| Q7Z4V5 | S396 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EDDEPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKP |
| Q7Z4V5 | S399 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | EPVKKRGRKGRGRGPPsssDsEPEAELEREAKKSAKKPQSS |
| Q7Z6Z7 | S1907 | Sugiyama | HUWE1 KIAA0312 KIAA1578 UREB1 HSPC272 | EVANCCIRIALPAPRGsGtAsDDEFENLRIKGPNAVQLVKt |
| Q86UP2 | S77 | Sugiyama | KTN1 CG1 KIAA0004 | AEKKKNKKKEIQNGNLHEsDsEsVPRDFKLSDALAVEDDQV |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86VM9 | S34 | Sugiyama | ZC3H18 NHN1 | PEDEEQPQGLsDDDILRDsGsDQDLDGAGVRAsDLEDEEsA |
| Q86VM9 | S46 | Sugiyama | ZC3H18 NHN1 | DDILRDsGsDQDLDGAGVRAsDLEDEEsAARGPsQEEEDNH |
| Q86WR0 | S204 | Sugiyama | CCDC25 | RSYssLMKVENMSSNQDGNDsDEFM________________ |
| Q8IV38 | S422 | Sugiyama | ANKMY2 | IsQKDSNPEDSGEGKKEsLEsEAELEGLQDAPAGPQVSEE_ |
| Q8IWA0 | S782 | Sugiyama | WDR75 UTP17 | KSAKEIPEDVDMEEEKEsEDsDEENDFTEKVQDtsNtGLGE |
| Q8IWW6 | S215 | Sugiyama | ARHGAP12 | QEQSCDSAGEGSERIHQDSEsGDELSSSsTEQIRAttPPNQ |
| Q8IYB3 | S802 | Sugiyama | SRRM1 SRM160 | PAVPVKKAKsPtPsPsPPRNsDQEGGGKKKKKKKDKKHKKD |
| Q8IYB3 | S874 | Sugiyama | SRRM1 SRM160 | tttLAQEEPVAAPEPKKEtEsEAEDNLDDLEKHLREKALRS |
| Q8IYB3 | T872 | Sugiyama | SRRM1 SRM160 | AAtttLAQEEPVAAPEPKKEtEsEAEDNLDDLEKHLREKAL |
| Q8IYB7 | S875 | Sugiyama | DIS3L2 FAM6A | AILKRPGTQGHLGPEKEEEEsDGEPEDssTS__________ |
| Q8N163 | T454 | SIGNOR | CCAR2 DBC1 KIAA1967 | PTLEEWEALCQQKAAEAAPPtQEAQGEtEPTEQAPDALEQA |
| Q8N6N3 | S158 | Sugiyama | C1orf52 BAG GM117 | DAPQNAKKARLLPEGEEtLEsDDEKDEHtsKKRKVEPGEPA |
| Q8ND56 | S374 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | EDPLGPNCYYDKTKsFFDNIsCDDNRERRPtWAEERRLNAE |
| Q8NE71 | S109 | Sugiyama | ABCF1 ABC50 | DDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKGG |
| Q8NE71 | S140 | Sugiyama | ABCF1 ABC50 | PRGGKKTKGGNVFAALIQDQsEEEEEEEKHPPKPAKPEKNR |
| Q8NE71 | T108 | Sugiyama | ABCF1 ABC50 | VDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKKTKG |
| Q8NEN9 | S496 | Sugiyama | PDZD8 PDZK8 | SGYEEEAAGLTVDTESRELDsEFEDLAsDVRAQNEFKDEAQ |
| Q8NHW5 | S304 | Sugiyama | RPLP0P6 | DTTAAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD_______ |
| Q8NHW5 | S307 | Sugiyama | RPLP0P6 | AAPAAAAAPAKVEAKEEsEEsDEDMGFGLFD__________ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8WVC0 | S66 | Sugiyama | LEO1 RDL | DQDERGDSGQPSNKELFGDDsEDEGAsHHsGSDNHSERSDN |
| Q8WXI9 | S129 | Sugiyama | GATAD2B KIAA1150 | ARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAA |
| Q92478 | S127 | Sugiyama | CLEC2B AICL CLECSF2 IFNRG1 | DGATFTKSFGMRGSEGCAYLsDDGAATARCYTERKWICRKR |
| Q92598 | S509 | SIGNOR|iPTMNet | HSPH1 HSP105 HSP110 KIAA0201 | IFTISTASMVEKVPtEENEMssEADMECLNQRPPENPDTDK |
| Q92614 | S1970 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | NSLQDMVTKYQKRKNKLEGDsDVDsELEDRVDGVKSWLSKN |
| Q92614 | S1974 | Sugiyama | MYO18A CD245 KIAA0216 MYSPDZ TIAF1 | DMVTKYQKRKNKLEGDsDVDsELEDRVDGVKSWLSKNKGPS |
| Q92626 | S1300 | Sugiyama | PXDN KIAA0230 MG50 PRG2 PXD01 VPO VPO1 | NITRVQSDVFRVAEFPHGyGsCDEIPRVDLRVWQDCCEDCR |
| Q92769 | S394 | SIGNOR|ELM|Sugiyama | HDAC2 | LPHAPGVQMQAIPEDAVHEDsGDEDGEDPDKRIsIRAsDKR |
| Q92769 | S422 | SIGNOR|ELM|Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92769 | S424 | SIGNOR|ELM|Sugiyama | HDAC2 | KRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGAKK |
| Q92915 | S228 | SIGNOR | FGF14 FHF4 | EPSLHDVGETVPKPGVTPsKsTsASAIMNGGKPVNKSKTT_ |
| Q92915 | S230 | SIGNOR | FGF14 FHF4 | SLHDVGETVPKPGVTPsKsTsASAIMNGGKPVNKSKTT___ |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q96B36 | S202 | Sugiyama | AKT1S1 PRAS40 | KsLPVSVPVWGFKEKRtEARssDEENGPPssPDLDRIAAsM |
| Q96B36 | S203 | Sugiyama | AKT1S1 PRAS40 | sLPVSVPVWGFKEKRtEARssDEENGPPssPDLDRIAAsMR |
| Q96C86 | T25 | Sugiyama | DCPS DCS1 HINT5 HSPC015 | APQLGKRKRELDVEEAHAAstEEKEAGVGNGTCAPVRLPFS |
| Q96CW6 | S302 | Sugiyama | SLC7A6OS | SRQRMWSKYPLDVQKEFGyDsPHDLDsD_____________ |
| Q96CW6 | S308 | Sugiyama | SLC7A6OS | SKYPLDVQKEFGyDsPHDLDsD___________________ |
| Q96D15 | T127 | Sugiyama | RCN3 UNQ239/PRO272 | AHTQQRHIRDsVsAAWDtyDtDRDGRVGWEELRNATYGHYA |
| Q96D46 | S468 | Sugiyama | NMD3 CGI-07 | EDEAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAEMLEDLH |
| Q96D46 | T470 | Sugiyama | NMD3 CGI-07 | EAIRKNVNIyRDsAIPVEsDtDDEGAPRISLAEMLEDLHIs |
| Q96EV2 | S205 | Sugiyama | RBM33 PRR8 | LDEFTGGMETLELQKDIKEEsDEEEEDDEEsGRLRFKTERK |
| Q96I25 | S155 | Sugiyama | RBM17 SPF45 | EKRRKDRHEASGFARRPDPDsDEDEDYERERRKRsMGGAAI |
| Q96KC8 | S479 | Sugiyama | DNAJC1 HTJ1 | PEEKSRAKRQKDFDIAEQNEssDEEsLRKERARsAEEPWTQ |
| Q96KC8 | S480 | Sugiyama | DNAJC1 HTJ1 | EEKSRAKRQKDFDIAEQNEssDEEsLRKERARsAEEPWTQN |
| Q96MW1 | T139 | Sugiyama | CCDC43 | MVSEEEKQRKAALLAQyADVtDEEDEADEKDDsGAttMNIG |
| Q96NB3 | S351 | Sugiyama | ZNF830 CCDC16 | KLKEILTIKELQKKEEENADsDDEGELQDLLSQDWRVKGAL |
| Q96QK1 | S759 | Sugiyama | VPS35 MEM3 TCCCTA00141 | TIQVLNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRL |
| Q96S55 | S436 | Sugiyama | WRNIP1 WHIP | SSSEPAMFIEDKAVDTLAYLsDGDARAGLNGLQLAVLARLS |
| Q96S59 | T596 | Sugiyama | RANBP9 RANBPM | SSNGFLNGSSKHDHEMEDCDtEMEVDSsQLRRQLCGGsQAA |
| Q96S90 | S99 | Sugiyama | LYSMD1 SB145 | KKTLYIPILTEPRDLFNGLDsEEEKDGEEKVHPSNSEVWPH |
| Q96SB4 | S51 | PSP | SRPK1 | RGsAPHSESDLPEQEEEILGsDDDEQEDPNDYCKGGYHLVK |
| Q96SB4 | S555 | PSP | SRPK1 | WSTACMAFELATGDYLFEPHsGEEYTRDEDHIALIIELLGK |
| Q96ST2 | S398 | Sugiyama | IWS1 IWS1L | DEDEKEGEEEKVAKRKAAVLsDsEDEEKAsAKKSRVVsDAD |
| Q96ST2 | S415 | Sugiyama | IWS1 IWS1L | AVLsDsEDEEKAsAKKSRVVsDADDsDsDAVsDKsGKREKt |
| Q96ST2 | S420 | Sugiyama | IWS1 IWS1L | sEDEEKAsAKKSRVVsDADDsDsDAVsDKsGKREKtIAsDs |
| Q96ST2 | S422 | Sugiyama | IWS1 IWS1L | DEEKAsAKKSRVVsDADDsDsDAVsDKsGKREKtIAsDsEE |
| Q96T88 | S91 | Sugiyama | UHRF1 ICBP90 NP95 RNF106 | LLVRQsLVLPHSTKERDsELsDtDsGCCLGQSESDKsstHG |
| Q99250 | S1112 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | YMSFINNPSLTVTVPIAVGEsDFENLNTEEFSsEsDMEESK |
| Q99250 | S1124 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | TVPIAVGEsDFENLNTEEFSsEsDMEESKEKLNATSSSEGS |
| Q99250 | S1126 | SIGNOR | SCN2A HBA NAC2 SCN2A1 SCN2A2 | PIAVGEsDFENLNTEEFSsEsDMEESKEKLNATSSSEGSTV |
| Q99523 | S825 | Sugiyama | SORT1 | DGVDALDtAsHtNKsGYHDDsDEDLLE______________ |
| Q99543 | S60 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | KRRNRNAsAsFQELEDKKELsEEsEDEELQLEEFPMLKTLD |
| Q99543 | S63 | Sugiyama | DNAJC2 MPHOSPH11 MPP11 ZRF1 | NRNAsAsFQELEDKKELsEEsEDEELQLEEFPMLKTLDPKD |
| Q99613 | S39 | Sugiyama | EIF3C EIF3S8 | GEELVTKPVGGNyGKQPLLLsEDEEDTKRVVRSAKDKRFEE |
| Q99614 | S90 | Sugiyama | TTC1 TPR1 | FEEEPGADKVENKsNEDVNssELDEEyLIELEKNMSDEEKQ |
| Q99733 | S121 | Sugiyama | NAP1L4 NAP2 | PLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKV |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99733 | T117 | Sugiyama | NAP1L4 NAP2 | ALyQPLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDM |
| Q99801 | T89 | SIGNOR|PSP | NKX3-1 NKX3.1 NKX3A | AGAQNDQLSTGPRAAPEEAEtLAEtEPERHLGSYLLDSENT |
| Q99801 | T93 | SIGNOR|PSP | NKX3-1 NKX3.1 NKX3A | NDQLSTGPRAAPEEAEtLAEtEPERHLGSYLLDSENTSGAL |
| Q9BPX3 | S674 | Sugiyama | NCAPG CAPG NYMEL3 | IEPFKTKKIKTLHCEGtEINsDDEQEsKEVEETATAKNVLK |
| Q9BQA1 | S185 | Sugiyama | WDR77 MEP50 WD45 HKMT1069 Nbla10071 | AHAAQVTCVAAsPHKDSVFLsCSEDNRILLWDTRCPKPASQ |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BRS2 | S21 | Sugiyama | RIOK1 RIO1 | MDYRRLLMSRVVPGQFDDADssDsENRDLKTVKEKDDILFE |
| Q9BRS2 | S22 | Sugiyama | RIOK1 RIO1 | DYRRLLMSRVVPGQFDDADssDsENRDLKTVKEKDDILFED |
| Q9BTC0 | S154 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | ERPASSEKVKGGDDHDDtsDsDsDGLTLKELQNRLRRKREQ |
| Q9BUJ2 | T534 | Sugiyama | HNRNPUL1 E1BAP5 HNRPUL1 | QRRKMRPFEGFQRKAIVICPtDEDLKDRTIKRTDEEGKDVP |
| Q9BUL5 | S315 | Sugiyama | PHF23 | PADSESKEVGsTETSQDGDAsssEGEMRVMDEDIMVESGDD |
| Q9BVJ6 | S29 | Sugiyama | UTP14A SDCCAG16 | sLLALsQQEELADLPKDyLLsEsEDEGDNDGERKHQKLLEA |
| Q9BVJ6 | S31 | Sugiyama | UTP14A SDCCAG16 | LALsQQEELADLPKDyLLsEsEDEGDNDGERKHQKLLEAIs |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BYW2 | S1413 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | LEKNDIKDRGPLKKRRQEIEsDsEsDGELQDRKKVRVEVEQ |
| Q9BYW2 | S1417 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | DIKDRGPLKKRRQEIEsDsEsDGELQDRKKVRVEVEQGETS |
| Q9BYX2 | S920 | Sugiyama | TBC1D2 PARIS1 PP8997 TBC1D2A | KAEyLERRASRRRAVsEGCAsEDEVEGEA____________ |
| Q9BZI7 | T169 | Sugiyama | UPF3B RENT3B UPF3X | TKVGtIDDDPEyRKFLEsyAtDNEKMTstPEtLLEEIEAKN |
| Q9GZL7 | T221 | Sugiyama | WDR12 | GTKFCsGSWDKMLKIWStVPtDEEDEMEEsTNRPRKKQKTE |
| Q9H0D6 | S499 | Sugiyama | XRN2 | sFtsDGsPsPLGGIKRKAEDsDsEPEPEDNVRLWEAGWKQR |
| Q9H0D6 | S501 | Sugiyama | XRN2 | tsDGsPsPLGGIKRKAEDsDsEPEPEDNVRLWEAGWKQRYY |
| Q9H1E3 | S113 | Sugiyama | NUCKS1 NUCKS JC7 | RQAASKAASKQREMLMEDVGsEEEQEEEDEAPFQEKDsGsD |
| Q9H1E3 | S132 | Sugiyama | NUCKS1 NUCKS JC7 | GsEEEQEEEDEAPFQEKDsGsDEDFLMEDDDDsDyGSsKKK |
| Q9H1E3 | S144 | Sugiyama | NUCKS1 NUCKS JC7 | PFQEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPER |
| Q9H2G2 | S347 | Sugiyama | SLK KIAA0204 STK2 | tENsLPIPAsKRAssDLsIAssEEDKLsQNACILEsVSEKt |
| Q9H2P0 | S953 | Sugiyama | ADNP ADNP1 KIAA0784 | GSKYETIHLTEEPTKLMHNAsDsEVDQDDVVEWKDGAsPsE |
| Q9H2P0 | S955 | Sugiyama | ADNP ADNP1 KIAA0784 | KYETIHLTEEPTKLMHNAsDsEVDQDDVVEWKDGAsPsESG |
| Q9H307 | S347 | Sugiyama | PNN DRS MEMA | NDVEIEEAGEEEEKEIAIVHsDAEKEQEEEEQKQEMEVKME |
| Q9H501 | S75 | Sugiyama | ESF1 ABTAP C20orf6 HDCMC28P | KRGRPISHSTTEDLKRFyDLsDsDsNLsGEDSKALSQKKIK |
| Q9H6Y2 | S14 | Sugiyama | WDR55 | _______MDRTCEERPAEDGsDEEDPDsMEAPTRIRDtPED |
| Q9H6Z4 | S108 | Sugiyama | RANBP3 | FPRELAGRsAGGssPEGGEDsDREDGNyCPPVKRERtssLt |
| Q9HCN4 | S338 | Sugiyama | GPN1 MBDIN RPAP4 XAB1 HUSSY-23 | HPsDLILtRGTLDEEDEEADsDtDDIDHRVTEESHEEPAFQ |
| Q9NPQ8 | S436 | Sugiyama | RIC8A | AAGLLAARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPV |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NQ55 | S359 | Sugiyama | PPAN BXDC3 SSF1 | QREAHRKKSLEGMKKARVGGsDEEAsGIPsRTASLELGEDD |
| Q9NQB0 | S58 | SIGNOR|ELM | TCF7L2 TCF4 | ERDLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDK |
| Q9NQB0 | S59 | SIGNOR|ELM | TCF7L2 TCF4 | RDLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDKS |
| Q9NQB0 | S60 | SIGNOR|ELM | TCF7L2 TCF4 | DLADVKSSLVNESEtNQNsssDSEAERRPPPRSESFRDKSR |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NTJ3 | S27 | Sugiyama | SMC4 CAPC SMC4L1 | QPSTARRREEGPPPPsPDGAssDAEPEPPsGRtEsPAtAAE |
| Q9NVU7 | S585 | Sugiyama | SDAD1 NUC130 | RKELDAAPGKSQKRKyIEIDsDEEPRGELLsLRDIERLHKK |
| Q9NXG2 | S86 | Sugiyama | THUMPD1 | NEYGDDMYGPEKFtDKDQQPsGsEGEDDDAEAALKKEVGDI |
| Q9NXG2 | S88 | Sugiyama | THUMPD1 | YGDDMYGPEKFtDKDQQPsGsEGEDDDAEAALKKEVGDIKA |
| Q9NYF8 | S385 | Sugiyama | BCLAF1 BTF KIAA0164 | GSEKGRAEGEWEDQEALDyFsDKEsGKQKFNDsEGDDtEEt |
| Q9NZV7 | S155 | Sugiyama | ZIM2 ZNF656 | LAQDSVPAEKRNTEMLDNLPsAGsQFPDFKHLGTFLVFEEL |
| Q9NZV7 | S158 | Sugiyama | ZIM2 ZNF656 | DSVPAEKRNTEMLDNLPsAGsQFPDFKHLGTFLVFEELVTF |
| Q9P258 | S50 | Sugiyama | RCC2 KIAA1470 TD60 | GPAGRKRERPERCssssGGGssGDEDGLELDGAPGGGKRAA |
| Q9P258 | S51 | Sugiyama | RCC2 KIAA1470 TD60 | PAGRKRERPERCssssGGGssGDEDGLELDGAPGGGKRAAR |
| Q9P2I0 | S419 | Sugiyama | CPSF2 CPSF100 KIAA1367 | EKLKKEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKH |
| Q9P2I0 | S420 | Sugiyama | CPSF2 CPSF100 KIAA1367 | KLKKEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKHD |
| Q9P2I0 | S423 | Sugiyama | CPSF2 CPSF100 KIAA1367 | KEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKHDLMM |
| Q9UBE0 | S12 | Sugiyama | SAE1 AOS1 SUA1 UBLE1A | _________MVEKEEAGGGIsEEEAAQyDRQIRLWGLEAQK |
| Q9UBF6 | T10 | ELM | RNF7 RBX2 ROC2 SAG | ___________MADVEDGEEtCALAsHsGssGsKSGGDKMF |
| Q9UBS4 | S78 | Sugiyama | DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080 | PDDPQAQEKFQDLGAAyEVLsDSEKRKQyDTyGEEGLKDGH |
| Q9UD71 | S102 | SIGNOR | PPP1R1B DARPP32 | VQRIAESHLQSIsNLNENQAsEEEDELGELRELGYPREEDE |
| Q9UD71 | S45 | SIGNOR | PPP1R1B DARPP32 | VEMIRRRRPtPAMLFRLsEHssPEEEAsPHQRASGEGHHLK |
| Q9UD71 | S66 | iPTMNet | PPP1R1B DARPP32 | sPEEEAsPHQRASGEGHHLKsKRPNPCAYtPPSLKAVQRIA |
| Q9UDY2 | S430 | Sugiyama | TJP2 X104 ZO2 | sNRsFsPEERRHQysDyDyHsssEKLKERPssREDtPSRLS |
| Q9UH62 | S61 | Sugiyama | ARMCX3 ALEX3 BM-017 UNQ2517/PRO6007 | GGsGDVDDAGDCsGARyNDWsDDDDDsNESKsIVWYPPWAR |
| Q9UHI6 | S652 | Sugiyama | DDX20 DP103 GEMIN3 | RNKVIEQRVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKs |
| Q9UHI6 | S654 | Sugiyama | DDX20 DP103 GEMIN3 | KVIEQRVPVLASSsQsGDsEsDSDSySSRTSSQSKGNKsyL |
| Q9UHX1 | S238 | Sugiyama | PUF60 FIR ROBPI SIAHBP1 | LAEEARAFNRIyVAsVHQDLsDDDIKSVFEAFGKIKSCTLA |
| Q9UKS6 | S276 | Sugiyama | PACSIN3 | SSSEKFHELHRDLHQGIEAAsDEEDLRWWRSTHGPGMAMNW |
| Q9UKX7 | S52 | Sugiyama | NUP50 NPAP60L PRO1146 | EEVLKNRAIKKAKRRNVGFEsDtGGAFKGFKGLVVPSGGGR |
| Q9UKY7 | S107 | Sugiyama | CDV3 H41 | ELEQKEVDysGLRVQAMQIssEKEEDDNEKRQDPGDNWEEG |
| Q9UNN4 | S356 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | IRVTDDDIGEIIQVDGSGDTssNEEIGSTRDADENEFLGNI |
| Q9UNN4 | S357 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | RVTDDDIGEIIQVDGSGDTssNEEIGSTRDADENEFLGNID |
| Q9UNN4 | S418 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | TNSSDNEDPQVNIVEEDPLNsGDDVsEQDVPDLFDTDNVIV |
| Q9UNN4 | S423 | SIGNOR|ELM|iPTMNet | GTF2A1L ALF GTF2A1LF | NEDPQVNIVEEDPLNsGDDVsEQDVPDLFDTDNVIVCQYDK |
| Q9UNN5 | S289 | ELM | FAF1 UBXD12 UBXN3A CGI-03 | ssPAQTREQSEEQITDVHMVsDsDGDDFEDATEFGVDDGEV |
| Q9UNN5 | S291 | ELM | FAF1 UBXD12 UBXN3A CGI-03 | PAQTREQSEEQITDVHMVsDsDGDDFEDATEFGVDDGEVFG |
| Q9UPR3 | S480 | Sugiyama | SMG5 EST1B KIAA1089 | RRRRHPPKVGDDSDLsEGFEsDSSHDSARASEGSDSGSDKS |
| Q9UQ88 | S265 | Sugiyama | CDK11A CDC2L2 CDC2L3 PITSLREB | APAQKPAQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSA |
| Q9UQ88 | S271 | Sugiyama | CDK11A CDC2L2 CDC2L3 PITSLREB | AQLKEEKMEERDLLsDLQDIsDsERKTSSAESSSAESGSGS |
| Q9UQE7 | S1067 | SIGNOR|PSP | SMC3 BAM BMH CSPG6 SMC3L1 | LVPGGKATLVMKKGDVEGsQsQDEGEGsGEsERGsGsQssV |
| Q9Y237 | S19 | ELM | PIN4 | __MPPKGKSGSGKAGKGGAAsGSDSADKKAQGPKGGGNAVK |
| Q9Y266 | S277 | Sugiyama | NUDC | LVssDPEINtKKINPENsKLsDLDsEtRsMVEKMMYDQRQK |
| Q9Y2B0 | S116 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | IDPstHRKNYVRVVGRNGEssELDLQGIRIDsDISGtLKFA |
| Q9Y2X3 | S502 | Sugiyama | NOP58 NOL5 NOP5 HSPC120 | TsVKKKKKRGKKKHIKEEPLsEEEPCtstAIAsPEKKKKKK |
| Q9Y3F4 | S254 | Sugiyama | STRAP MAWD UNRIP | EKEFLVAGGEDFKLyKyDyNsGEELEsyKGHFGPIHCVRFS |
| Q9Y3P9 | T996 | Sugiyama | RABGAP1 HSPC094 | FNKEGRVKGISSTKEVLDEDtDEEKETLKNQLREMELELAQ |
| Q9Y3T9 | S672 | Sugiyama | NOC2L NIR | KMADRKDEDRKQFKDLFDLNssEEDDtEGFsERGILRPLSt |
| Q9Y3T9 | S673 | Sugiyama | NOC2L NIR | MADRKDEDRKQFKDLFDLNssEEDDtEGFsERGILRPLStR |
| Q9Y5B0 | S575 | SIGNOR|ELM|iPTMNet | CTDP1 FCP1 | ETESQNSELSGVTAGESLDQsMEEEEEEDtDEDDHLIYLEE |
| Q9Y5B0 | S740 | SIGNOR|ELM|iPTMNet | CTDP1 FCP1 | KVEEQLFPLRDDHTKAQRENsPAAFPDREGVPPTALFHPMP |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y696 | S236 | Sugiyama | CLIC4 | GIWRYLtNAysRDEFtNtCPsDKEVEIAysDVAKRLTK___ |
| Q9Y696 | S27 | Sugiyama | CLIC4 | LNGLKEEDKEPLIELFVKAGsDGEsIGNCPFSQRLFMILWL |
| Q9Y6X9 | S743 | Sugiyama | MORC2 KIAA0852 ZCWCC1 | tEsPIKLsPAtPsRKRsVAVsDEEEVEEEAERRKERCKRGR |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.994125e-10 | 9.700 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.124462e-08 | 7.949 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.040058e-09 | 8.044 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.883298e-09 | 8.162 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.218657e-08 | 7.654 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 2.601576e-07 | 6.585 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.052227e-06 | 5.218 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.913120e-05 | 4.718 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.618933e-05 | 4.582 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.450798e-05 | 4.462 | 1 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.261280e-04 | 3.899 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.709437e-04 | 3.767 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.744934e-04 | 3.758 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.690528e-04 | 3.772 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.108327e-04 | 3.676 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.199055e-04 | 3.658 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.574878e-04 | 3.589 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.489679e-04 | 3.604 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.423549e-04 | 3.466 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.993420e-04 | 3.222 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 9.762785e-04 | 3.010 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.179369e-03 | 2.928 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.314560e-03 | 2.881 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.992209e-03 | 2.701 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.363751e-03 | 2.626 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.250071e-03 | 2.648 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.453657e-03 | 2.610 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.429495e-03 | 2.614 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.366986e-03 | 2.626 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 2.515524e-03 | 2.599 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.862170e-03 | 2.543 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.911856e-03 | 2.536 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 3.383903e-03 | 2.471 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.368248e-03 | 2.473 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.342826e-03 | 2.476 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.437545e-03 | 2.464 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.437545e-03 | 2.464 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.603185e-03 | 2.443 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.628123e-03 | 2.440 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.392410e-03 | 2.469 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 3.663967e-03 | 2.436 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.284638e-03 | 2.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.284638e-03 | 2.368 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.022373e-03 | 2.396 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.229662e-03 | 2.374 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 3.861958e-03 | 2.413 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.460403e-03 | 2.351 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.633264e-03 | 2.334 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.085502e-03 | 2.294 | 1 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.480514e-03 | 2.261 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 5.765120e-03 | 2.239 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.978387e-03 | 2.098 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.978387e-03 | 2.098 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.978387e-03 | 2.098 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.978387e-03 | 2.098 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.725651e-03 | 2.172 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.338972e-03 | 2.134 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.506104e-03 | 2.187 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 6.160025e-03 | 2.210 | 1 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 6.950453e-03 | 2.158 | 1 | 1 |
| Signaling by ALK | R-HSA-201556 | 7.843876e-03 | 2.105 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 6.950453e-03 | 2.158 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 6.950453e-03 | 2.158 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 8.899012e-03 | 2.051 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.001461e-03 | 2.046 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 9.148611e-03 | 2.039 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.235776e-03 | 2.035 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 9.329270e-03 | 2.030 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.831405e-03 | 2.007 | 1 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 9.713962e-03 | 2.013 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.011885e-02 | 1.995 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.046853e-02 | 1.980 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.076911e-02 | 1.968 | 1 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.122816e-02 | 1.950 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.149230e-02 | 1.940 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.207833e-02 | 1.918 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.249806e-02 | 1.903 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.285667e-02 | 1.891 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.434318e-02 | 1.843 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.434318e-02 | 1.843 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.434318e-02 | 1.843 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.434318e-02 | 1.843 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.431524e-02 | 1.844 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.392017e-02 | 1.856 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.395610e-02 | 1.855 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.437267e-02 | 1.842 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.610596e-02 | 1.793 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.613306e-02 | 1.792 | 0 | 0 |
| SDK interactions | R-HSA-373756 | 1.761064e-02 | 1.754 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.786222e-02 | 1.748 | 1 | 1 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.156386e-02 | 1.666 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.971027e-02 | 1.705 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.241544e-02 | 1.649 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.008956e-02 | 1.697 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.008956e-02 | 1.697 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.008956e-02 | 1.697 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.272571e-02 | 1.643 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.272571e-02 | 1.643 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.272571e-02 | 1.643 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.241544e-02 | 1.649 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.062630e-02 | 1.686 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 1.870586e-02 | 1.728 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.272571e-02 | 1.643 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.984169e-02 | 1.702 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.984169e-02 | 1.702 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.108329e-02 | 1.676 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.203983e-02 | 1.657 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.203983e-02 | 1.657 | 1 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.937567e-02 | 1.713 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 1.870586e-02 | 1.728 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 2.018643e-02 | 1.695 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.387456e-02 | 1.622 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.387456e-02 | 1.622 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.387456e-02 | 1.622 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 2.468429e-02 | 1.608 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.472244e-02 | 1.607 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.512500e-02 | 1.600 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.641568e-02 | 1.578 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.985376e-02 | 1.525 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.023383e-02 | 1.520 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 3.023383e-02 | 1.520 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.099065e-02 | 1.509 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.105759e-02 | 1.508 | 1 | 0 |
| IRS activation | R-HSA-74713 | 3.435616e-02 | 1.464 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.401519e-02 | 1.468 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.401519e-02 | 1.468 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.246682e-02 | 1.489 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.614319e-02 | 1.442 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.669844e-02 | 1.435 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.789541e-02 | 1.421 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 4.443215e-02 | 1.352 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.237998e-02 | 1.373 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.027142e-02 | 1.395 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.308499e-02 | 1.366 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.340634e-02 | 1.362 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.156803e-02 | 1.381 | 1 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.064075e-02 | 1.391 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.435337e-02 | 1.353 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 4.435337e-02 | 1.353 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.735127e-02 | 1.325 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 4.779804e-02 | 1.321 | 1 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.073597e-02 | 1.295 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.073597e-02 | 1.295 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.092966e-02 | 1.293 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.142141e-02 | 1.289 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 5.160867e-02 | 1.287 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.406270e-02 | 1.267 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 5.410851e-02 | 1.267 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 6.202180e-02 | 1.207 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.857837e-02 | 1.232 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.857837e-02 | 1.232 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 5.970159e-02 | 1.224 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.876563e-02 | 1.231 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.388023e-02 | 1.195 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 5.848601e-02 | 1.233 | 1 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.202180e-02 | 1.207 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.102963e-02 | 1.214 | 1 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.444569e-02 | 1.191 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 6.487637e-02 | 1.188 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 6.545238e-02 | 1.184 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.565793e-02 | 1.183 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 6.610528e-02 | 1.180 | 1 | 1 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.750586e-02 | 1.171 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.874482e-02 | 1.163 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.943310e-02 | 1.158 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.078190e-02 | 1.093 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.078190e-02 | 1.093 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 8.078190e-02 | 1.093 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 8.078190e-02 | 1.093 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 7.936245e-02 | 1.100 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.392200e-02 | 1.131 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 7.168876e-02 | 1.145 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.427250e-02 | 1.129 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 8.014829e-02 | 1.096 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 7.168876e-02 | 1.145 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.917327e-02 | 1.101 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 7.936245e-02 | 1.100 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 7.936245e-02 | 1.100 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.977028e-02 | 1.098 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.116436e-02 | 1.148 | 1 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 7.930461e-02 | 1.101 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.930461e-02 | 1.101 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.542946e-02 | 1.020 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.542946e-02 | 1.020 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.542946e-02 | 1.020 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.542946e-02 | 1.020 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.542946e-02 | 1.020 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.542946e-02 | 1.020 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.542946e-02 | 1.020 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 9.062339e-02 | 1.043 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.062339e-02 | 1.043 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 9.383033e-02 | 1.028 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 9.511202e-02 | 1.022 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 8.253027e-02 | 1.083 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 8.253027e-02 | 1.083 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 8.578700e-02 | 1.067 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 8.578700e-02 | 1.067 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 8.578700e-02 | 1.067 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 8.578700e-02 | 1.067 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 8.578700e-02 | 1.067 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 8.587988e-02 | 1.066 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.168980e-02 | 1.038 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.454720e-02 | 1.024 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.439523e-02 | 1.074 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.028429e-02 | 1.044 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 9.062339e-02 | 1.043 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 9.062339e-02 | 1.043 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.362289e-02 | 1.078 | 1 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.959069e-02 | 1.048 | 1 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 9.041114e-02 | 1.044 | 1 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 9.433798e-02 | 1.025 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 8.271758e-02 | 1.082 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 8.318786e-02 | 1.080 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.592317e-02 | 1.018 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.659939e-02 | 1.015 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 9.827690e-02 | 1.008 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.013944e-01 | 0.994 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.013944e-01 | 0.994 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.013944e-01 | 0.994 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.029433e-01 | 0.987 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.035519e-01 | 0.985 | 1 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.059193e-01 | 0.975 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.096487e-01 | 0.960 | 1 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.817572e-01 | 0.741 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.817572e-01 | 0.741 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.817572e-01 | 0.741 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.817572e-01 | 0.741 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.817572e-01 | 0.741 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.817572e-01 | 0.741 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.817572e-01 | 0.741 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.224539e-01 | 0.912 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.224539e-01 | 0.912 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.224539e-01 | 0.912 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.224539e-01 | 0.912 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 2.598509e-01 | 0.585 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective CD320 causes MMATC | R-HSA-3359485 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.598509e-01 | 0.585 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.598509e-01 | 0.585 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.564929e-01 | 0.806 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.212088e-01 | 0.916 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.920298e-01 | 0.717 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.920298e-01 | 0.717 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.920298e-01 | 0.717 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.304955e-01 | 0.481 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.304955e-01 | 0.481 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.304955e-01 | 0.481 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.304955e-01 | 0.481 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.304955e-01 | 0.481 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.436973e-01 | 0.843 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.284690e-01 | 0.641 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.674278e-01 | 0.776 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.438196e-01 | 0.842 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.653152e-01 | 0.576 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.653152e-01 | 0.576 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 2.653152e-01 | 0.576 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 3.944010e-01 | 0.404 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 3.944010e-01 | 0.404 | 0 | 0 |
| Defective ABCD4 causes MAHCJ | R-HSA-5683329 | 3.944010e-01 | 0.404 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.944010e-01 | 0.404 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.944010e-01 | 0.404 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.624066e-01 | 0.789 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 1.624066e-01 | 0.789 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.177982e-01 | 0.662 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 2.177982e-01 | 0.662 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.381051e-01 | 0.860 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.381051e-01 | 0.860 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.381051e-01 | 0.860 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.381051e-01 | 0.860 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.180749e-01 | 0.928 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.180749e-01 | 0.928 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.021590e-01 | 0.520 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.021590e-01 | 0.520 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.305011e-01 | 0.884 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.305011e-01 | 0.884 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 2.440460e-01 | 0.613 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.116347e-01 | 0.952 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.223990e-01 | 0.912 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.336727e-01 | 0.874 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 2.226498e-01 | 0.652 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.226498e-01 | 0.652 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.386657e-01 | 0.470 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 3.386657e-01 | 0.470 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.386657e-01 | 0.470 | 1 | 1 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.386657e-01 | 0.470 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.522100e-01 | 0.345 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.522100e-01 | 0.345 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.522100e-01 | 0.345 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 4.522100e-01 | 0.345 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 4.522100e-01 | 0.345 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 2.977619e-01 | 0.526 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.655812e-01 | 0.576 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.745640e-01 | 0.426 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 3.745640e-01 | 0.426 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.326443e-01 | 0.877 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.326443e-01 | 0.877 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.249045e-01 | 0.488 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 3.249045e-01 | 0.488 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.249045e-01 | 0.488 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.970092e-01 | 0.706 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.970092e-01 | 0.706 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.205079e-01 | 0.919 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.799158e-01 | 0.745 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 2.875918e-01 | 0.541 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.575478e-01 | 0.589 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.575478e-01 | 0.589 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.575478e-01 | 0.589 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.361777e-01 | 0.866 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.098441e-01 | 0.509 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.045039e-01 | 0.297 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.045039e-01 | 0.297 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.322514e-01 | 0.479 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.322514e-01 | 0.479 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.790453e-01 | 0.421 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.790453e-01 | 0.421 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.790453e-01 | 0.421 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.547316e-01 | 0.450 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.437174e-01 | 0.353 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.474242e-01 | 0.607 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.057986e-01 | 0.392 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.057986e-01 | 0.392 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.057986e-01 | 0.392 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.398295e-01 | 0.620 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.398295e-01 | 0.620 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.338742e-01 | 0.476 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.582117e-01 | 0.801 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.152212e-01 | 0.501 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 4.321995e-01 | 0.364 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.766732e-01 | 0.322 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 4.766732e-01 | 0.322 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 4.766732e-01 | 0.322 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.518083e-01 | 0.258 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.518083e-01 | 0.258 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.518083e-01 | 0.258 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.518083e-01 | 0.258 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.518083e-01 | 0.258 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.518083e-01 | 0.258 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.518083e-01 | 0.258 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.518083e-01 | 0.258 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.723560e-01 | 0.565 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 3.689827e-01 | 0.433 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 3.689827e-01 | 0.433 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 3.689827e-01 | 0.433 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.218587e-01 | 0.375 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.218587e-01 | 0.375 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.547506e-01 | 0.450 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.042210e-01 | 0.393 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.835969e-01 | 0.316 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.835969e-01 | 0.316 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.835969e-01 | 0.316 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.126478e-01 | 0.384 | 1 | 1 |
| Meiotic synapsis | R-HSA-1221632 | 4.126478e-01 | 0.384 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 4.126478e-01 | 0.384 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.393067e-01 | 0.357 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.287503e-01 | 0.368 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.084492e-01 | 0.294 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.945992e-01 | 0.226 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 5.945992e-01 | 0.226 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.945992e-01 | 0.226 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.945992e-01 | 0.226 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.945992e-01 | 0.226 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.945992e-01 | 0.226 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 5.945992e-01 | 0.226 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.945992e-01 | 0.226 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 5.945992e-01 | 0.226 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 5.945992e-01 | 0.226 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.945992e-01 | 0.226 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.280548e-01 | 0.369 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.326594e-01 | 0.274 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 5.679764e-01 | 0.246 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 5.679764e-01 | 0.246 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.679764e-01 | 0.246 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 5.679764e-01 | 0.246 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 4.843873e-01 | 0.315 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 5.323268e-01 | 0.274 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.574333e-01 | 0.254 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.789789e-01 | 0.237 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 5.957405e-01 | 0.225 | 0 | 0 |
| Removal of aminoterminal propeptides from gamma-carboxylated proteins | R-HSA-159782 | 6.333070e-01 | 0.198 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.333070e-01 | 0.198 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.333070e-01 | 0.198 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.733858e-01 | 0.242 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.883619e-01 | 0.230 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 6.044065e-01 | 0.219 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.221437e-01 | 0.206 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 6.194462e-01 | 0.208 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.295851e-01 | 0.201 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 6.295851e-01 | 0.201 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.453803e-01 | 0.190 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 6.453803e-01 | 0.190 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.427729e-01 | 0.192 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 6.471927e-01 | 0.189 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 6.683210e-01 | 0.175 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.683210e-01 | 0.175 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.683210e-01 | 0.175 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.683210e-01 | 0.175 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.683210e-01 | 0.175 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.683210e-01 | 0.175 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.624567e-01 | 0.179 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.624567e-01 | 0.179 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 2.373592e-01 | 0.625 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.222923e-01 | 0.206 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.311432e-01 | 0.365 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.082688e-01 | 0.294 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.970092e-01 | 0.706 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 1.571160e-01 | 0.804 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 3.806651e-01 | 0.419 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.437174e-01 | 0.353 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 3.482059e-01 | 0.458 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.201908e-01 | 0.284 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.656897e-01 | 0.332 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 3.996051e-01 | 0.398 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.311432e-01 | 0.365 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.818047e-01 | 0.740 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 1.694375e-01 | 0.771 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.745640e-01 | 0.426 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.096378e-01 | 0.388 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.348125e-01 | 0.629 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.265091e-01 | 0.279 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 5.943912e-01 | 0.226 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.954884e-01 | 0.529 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.835969e-01 | 0.316 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.739818e-01 | 0.324 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.675745e-01 | 0.435 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.439499e-01 | 0.842 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.970092e-01 | 0.706 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 4.393067e-01 | 0.357 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.921949e-01 | 0.716 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 3.745640e-01 | 0.426 | 1 | 1 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.521728e-01 | 0.818 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.550129e-01 | 0.810 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.393067e-01 | 0.357 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.223228e-01 | 0.282 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.261366e-01 | 0.899 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.261366e-01 | 0.899 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.707570e-01 | 0.567 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.923645e-01 | 0.308 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.942575e-01 | 0.306 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.079611e-01 | 0.294 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 5.445914e-01 | 0.264 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.386206e-01 | 0.269 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 6.624567e-01 | 0.179 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 6.650673e-01 | 0.177 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.081179e-01 | 0.294 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 2.486929e-01 | 0.604 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.885763e-01 | 0.411 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 4.666467e-01 | 0.331 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.298757e-01 | 0.482 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.331933e-01 | 0.477 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.653152e-01 | 0.576 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.021590e-01 | 0.520 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.745640e-01 | 0.426 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.745640e-01 | 0.426 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.834868e-01 | 0.736 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 1.970092e-01 | 0.706 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.109088e-01 | 0.676 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.960893e-01 | 0.708 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.326594e-01 | 0.274 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 5.957405e-01 | 0.225 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 5.492488e-01 | 0.260 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.019181e-01 | 0.695 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.974120e-01 | 0.224 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 5.883619e-01 | 0.230 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.686335e-01 | 0.773 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.591836e-01 | 0.798 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.032317e-01 | 0.692 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.217997e-01 | 0.375 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 3.703922e-01 | 0.431 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.830687e-01 | 0.234 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.522100e-01 | 0.345 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.541914e-01 | 0.812 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.045039e-01 | 0.297 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.437174e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.766732e-01 | 0.322 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 4.766732e-01 | 0.322 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.518083e-01 | 0.258 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.331933e-01 | 0.477 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.683210e-01 | 0.175 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 2.397286e-01 | 0.620 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.468829e-01 | 0.608 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.996051e-01 | 0.398 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 4.766732e-01 | 0.322 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 4.766732e-01 | 0.322 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.631960e-01 | 0.440 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.447970e-01 | 0.352 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.431217e-01 | 0.192 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.427729e-01 | 0.192 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.652725e-01 | 0.576 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.834868e-01 | 0.736 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.080161e-01 | 0.294 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.222923e-01 | 0.206 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.652725e-01 | 0.576 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 1.680026e-01 | 0.775 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 1.624066e-01 | 0.789 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.440460e-01 | 0.613 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.019181e-01 | 0.695 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.386657e-01 | 0.470 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.576774e-01 | 0.802 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 2.251581e-01 | 0.648 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.096378e-01 | 0.388 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.045039e-01 | 0.297 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.045039e-01 | 0.297 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 3.790453e-01 | 0.421 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 5.388581e-01 | 0.269 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.081179e-01 | 0.294 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.727648e-01 | 0.325 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 5.313170e-01 | 0.275 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.957405e-01 | 0.225 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.957405e-01 | 0.225 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 6.333070e-01 | 0.198 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.333070e-01 | 0.198 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.010228e-01 | 0.221 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.010228e-01 | 0.221 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 6.572254e-01 | 0.182 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.893627e-01 | 0.410 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.345758e-01 | 0.871 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.486929e-01 | 0.604 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.019181e-01 | 0.695 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 5.079611e-01 | 0.294 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.498552e-01 | 0.602 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.873271e-01 | 0.231 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.547506e-01 | 0.450 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 3.408873e-01 | 0.467 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.242550e-01 | 0.906 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.534367e-01 | 0.814 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.032317e-01 | 0.692 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.047747e-01 | 0.689 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.996051e-01 | 0.398 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.271134e-01 | 0.485 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.920298e-01 | 0.717 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 1.921949e-01 | 0.716 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.021590e-01 | 0.520 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.045039e-01 | 0.297 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 5.045039e-01 | 0.297 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 3.370513e-01 | 0.472 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 3.706633e-01 | 0.431 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 4.107198e-01 | 0.386 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.289772e-01 | 0.277 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.471927e-01 | 0.189 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.683210e-01 | 0.175 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.581764e-01 | 0.801 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.605573e-01 | 0.337 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.324232e-01 | 0.634 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 3.996051e-01 | 0.398 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 4.949987e-01 | 0.305 | 1 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.957405e-01 | 0.225 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.634114e-01 | 0.787 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.436973e-01 | 0.843 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.439028e-01 | 0.613 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.320673e-01 | 0.364 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 4.835969e-01 | 0.316 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 5.081179e-01 | 0.294 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 5.081179e-01 | 0.294 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 5.265091e-01 | 0.279 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 6.413136e-01 | 0.193 | 1 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.845678e-01 | 0.546 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 2.732968e-01 | 0.563 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 6.135740e-01 | 0.212 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.954884e-01 | 0.529 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.732968e-01 | 0.563 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.221271e-01 | 0.282 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 6.453803e-01 | 0.190 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 2.177982e-01 | 0.662 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 5.679764e-01 | 0.246 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.865206e-01 | 0.543 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.057986e-01 | 0.392 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 3.112679e-01 | 0.507 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 5.598176e-01 | 0.252 | 1 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.005612e-01 | 0.397 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.684800e-01 | 0.245 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.530554e-01 | 0.815 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.954884e-01 | 0.529 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.429805e-01 | 0.265 | 1 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.598509e-01 | 0.585 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 1.212088e-01 | 0.916 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.304955e-01 | 0.481 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.304955e-01 | 0.481 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.674278e-01 | 0.776 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.944010e-01 | 0.404 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 1.860543e-01 | 0.730 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.522100e-01 | 0.345 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.032317e-01 | 0.692 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.154063e-01 | 0.938 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 2.209123e-01 | 0.656 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.209123e-01 | 0.656 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 2.655812e-01 | 0.576 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.249045e-01 | 0.488 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.575478e-01 | 0.589 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.045039e-01 | 0.297 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.547316e-01 | 0.450 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 4.437174e-01 | 0.353 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 4.437174e-01 | 0.353 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.437174e-01 | 0.353 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.850716e-01 | 0.545 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.602584e-01 | 0.585 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.518083e-01 | 0.258 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.518083e-01 | 0.258 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.518083e-01 | 0.258 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.518083e-01 | 0.258 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.700949e-01 | 0.432 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 4.247491e-01 | 0.372 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.388581e-01 | 0.269 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.679764e-01 | 0.246 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 5.574333e-01 | 0.254 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.333070e-01 | 0.198 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.333070e-01 | 0.198 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 6.607456e-01 | 0.180 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.026711e-01 | 0.220 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 3.513937e-01 | 0.454 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.234921e-01 | 0.908 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.009756e-01 | 0.697 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.581812e-01 | 0.588 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 6.133701e-01 | 0.212 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 6.363930e-01 | 0.196 | 1 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 2.977619e-01 | 0.526 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.547316e-01 | 0.450 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.559050e-01 | 0.183 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.261366e-01 | 0.899 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 5.475480e-01 | 0.262 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 1.818047e-01 | 0.740 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.790453e-01 | 0.421 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.697154e-01 | 0.569 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 2.977619e-01 | 0.526 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.284690e-01 | 0.641 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 1.674278e-01 | 0.776 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.732968e-01 | 0.563 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.388581e-01 | 0.269 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.486868e-01 | 0.828 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.407300e-01 | 0.852 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 4.656897e-01 | 0.332 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 6.194462e-01 | 0.208 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 6.453803e-01 | 0.190 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.365683e-01 | 0.270 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.116347e-01 | 0.952 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.019181e-01 | 0.695 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.386657e-01 | 0.470 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.045039e-01 | 0.297 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.797495e-01 | 0.237 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.683210e-01 | 0.175 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.656897e-01 | 0.332 | 0 | 0 |
| Protein folding | R-HSA-391251 | 5.709439e-01 | 0.243 | 1 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.084492e-01 | 0.294 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.254127e-01 | 0.204 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 3.386657e-01 | 0.470 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.032317e-01 | 0.692 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.045039e-01 | 0.297 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.084492e-01 | 0.294 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.662046e-01 | 0.331 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 5.628452e-01 | 0.250 | 1 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.194462e-01 | 0.208 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.217997e-01 | 0.375 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.082688e-01 | 0.294 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.492488e-01 | 0.260 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 4.908286e-01 | 0.309 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.222923e-01 | 0.206 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.247783e-01 | 0.204 | 1 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.436973e-01 | 0.843 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 1.534367e-01 | 0.814 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.431217e-01 | 0.192 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 5.085723e-01 | 0.294 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.656897e-01 | 0.332 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 4.705236e-01 | 0.327 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.125661e-01 | 0.385 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.377036e-01 | 0.624 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.112679e-01 | 0.507 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.284690e-01 | 0.641 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.944010e-01 | 0.404 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.440460e-01 | 0.613 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.858765e-01 | 0.731 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 2.009756e-01 | 0.697 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.745640e-01 | 0.426 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 4.096378e-01 | 0.388 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.045039e-01 | 0.297 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.437174e-01 | 0.353 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.518083e-01 | 0.258 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.518083e-01 | 0.258 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.439057e-01 | 0.353 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.320673e-01 | 0.364 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.561816e-01 | 0.255 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 6.333070e-01 | 0.198 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.634120e-01 | 0.249 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 6.683210e-01 | 0.175 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.683210e-01 | 0.175 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 6.683210e-01 | 0.175 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 2.951019e-01 | 0.530 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 4.218587e-01 | 0.375 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 4.028123e-01 | 0.395 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.566618e-01 | 0.805 | 1 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.581582e-01 | 0.339 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 4.116729e-01 | 0.385 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.265091e-01 | 0.279 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.233803e-01 | 0.281 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.920298e-01 | 0.717 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 2.440460e-01 | 0.613 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 6.071546e-01 | 0.217 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.135340e-01 | 0.212 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.321995e-01 | 0.364 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 6.248791e-01 | 0.204 | 1 | 1 |
| Signaling by TGFB family members | R-HSA-9006936 | 1.897065e-01 | 0.722 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.033400e-01 | 0.692 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 2.875918e-01 | 0.541 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 4.096378e-01 | 0.388 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.954884e-01 | 0.529 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.538349e-01 | 0.451 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 5.326594e-01 | 0.274 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 4.933947e-01 | 0.307 | 0 | 0 |
| Kinesins | R-HSA-983189 | 5.233803e-01 | 0.281 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 4.320673e-01 | 0.364 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.694375e-01 | 0.771 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 3.006291e-01 | 0.522 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.690525e-01 | 0.245 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 1.541914e-01 | 0.812 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 5.492488e-01 | 0.260 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.649902e-01 | 0.438 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 3.304955e-01 | 0.481 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.653152e-01 | 0.576 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.381051e-01 | 0.860 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.021590e-01 | 0.520 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.522100e-01 | 0.345 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.745640e-01 | 0.426 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.745640e-01 | 0.426 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.109088e-01 | 0.676 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 2.047931e-01 | 0.689 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.045039e-01 | 0.297 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.045039e-01 | 0.297 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.518083e-01 | 0.258 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.518083e-01 | 0.258 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.082688e-01 | 0.294 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.679764e-01 | 0.246 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 5.957405e-01 | 0.225 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.333070e-01 | 0.198 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 6.333070e-01 | 0.198 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.333070e-01 | 0.198 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.683210e-01 | 0.175 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 2.707570e-01 | 0.567 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.032317e-01 | 0.692 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.435577e-01 | 0.191 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.464239e-01 | 0.189 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 5.797316e-01 | 0.237 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 3.305056e-01 | 0.481 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 4.213674e-01 | 0.375 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 3.386657e-01 | 0.470 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 1.564929e-01 | 0.806 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.920298e-01 | 0.717 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.653152e-01 | 0.576 | 0 | 0 |
| Expression and Processing of Neurotrophins | R-HSA-9036866 | 3.944010e-01 | 0.404 | 0 | 0 |
| NGF processing | R-HSA-167060 | 3.944010e-01 | 0.404 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.707570e-01 | 0.567 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.386657e-01 | 0.470 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.977619e-01 | 0.526 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.977619e-01 | 0.526 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.096378e-01 | 0.388 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.045039e-01 | 0.297 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.006291e-01 | 0.522 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.518083e-01 | 0.258 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.945992e-01 | 0.226 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 5.679764e-01 | 0.246 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.542722e-01 | 0.256 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 6.650673e-01 | 0.177 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 1.180749e-01 | 0.928 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.517566e-01 | 0.819 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.019181e-01 | 0.695 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 5.326594e-01 | 0.274 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.466520e-01 | 0.189 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 1.627524e-01 | 0.788 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.675745e-01 | 0.435 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.438196e-01 | 0.842 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.386657e-01 | 0.470 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.745640e-01 | 0.426 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.341559e-01 | 0.198 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.683210e-01 | 0.175 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.194462e-01 | 0.208 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.945992e-01 | 0.226 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.945992e-01 | 0.226 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.683210e-01 | 0.175 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.683210e-01 | 0.175 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.602708e-01 | 0.180 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 6.254127e-01 | 0.204 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.445914e-01 | 0.264 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 2.505068e-01 | 0.601 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.333070e-01 | 0.198 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.427729e-01 | 0.192 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.177254e-01 | 0.498 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.492488e-01 | 0.260 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.745640e-01 | 0.426 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.321995e-01 | 0.364 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.471927e-01 | 0.189 | 0 | 0 |
| Synthesis and processing of ENV and VPU | R-HSA-171286 | 3.304955e-01 | 0.481 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.871593e-01 | 0.312 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.942575e-01 | 0.306 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.699714e-01 | 0.174 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.709054e-01 | 0.173 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.709054e-01 | 0.173 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 6.709054e-01 | 0.173 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.709054e-01 | 0.173 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.709054e-01 | 0.173 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.762111e-01 | 0.170 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 6.768525e-01 | 0.170 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.768525e-01 | 0.170 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 6.778329e-01 | 0.169 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 6.812294e-01 | 0.167 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.813407e-01 | 0.167 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.813407e-01 | 0.167 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.813407e-01 | 0.167 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.900812e-01 | 0.161 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.900812e-01 | 0.161 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 6.901575e-01 | 0.161 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 6.928623e-01 | 0.159 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 6.928623e-01 | 0.159 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 6.928623e-01 | 0.159 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 6.933085e-01 | 0.159 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.933085e-01 | 0.159 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.933085e-01 | 0.159 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.972168e-01 | 0.157 | 1 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 6.994268e-01 | 0.155 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.994268e-01 | 0.155 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.994268e-01 | 0.155 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.994268e-01 | 0.155 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.999935e-01 | 0.155 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 6.999935e-01 | 0.155 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.999935e-01 | 0.155 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.999935e-01 | 0.155 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.999935e-01 | 0.155 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 6.999935e-01 | 0.155 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.999935e-01 | 0.155 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 6.999935e-01 | 0.155 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.999935e-01 | 0.155 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.999935e-01 | 0.155 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 6.999935e-01 | 0.155 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 6.999935e-01 | 0.155 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 6.999935e-01 | 0.155 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 7.001966e-01 | 0.155 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.024523e-01 | 0.153 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.024523e-01 | 0.153 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 7.024523e-01 | 0.153 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.027028e-01 | 0.153 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.027960e-01 | 0.153 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.038793e-01 | 0.153 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 7.041944e-01 | 0.152 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 7.139601e-01 | 0.146 | 1 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 7.144358e-01 | 0.146 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 7.144358e-01 | 0.146 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.144358e-01 | 0.146 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.144358e-01 | 0.146 | 1 | 1 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.144358e-01 | 0.146 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.153750e-01 | 0.145 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.167213e-01 | 0.145 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.167213e-01 | 0.145 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.167213e-01 | 0.145 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.167907e-01 | 0.145 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.177818e-01 | 0.144 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.231611e-01 | 0.141 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 7.244006e-01 | 0.140 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 7.244902e-01 | 0.140 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 7.260441e-01 | 0.139 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.272194e-01 | 0.138 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.277193e-01 | 0.138 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.286432e-01 | 0.137 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.286432e-01 | 0.137 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 7.286432e-01 | 0.137 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.286432e-01 | 0.137 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 7.286432e-01 | 0.137 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 7.286432e-01 | 0.137 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 7.286432e-01 | 0.137 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.286432e-01 | 0.137 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 7.305010e-01 | 0.136 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 7.309192e-01 | 0.136 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.309192e-01 | 0.136 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 7.309192e-01 | 0.136 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 7.343268e-01 | 0.134 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 7.343268e-01 | 0.134 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.343268e-01 | 0.134 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.343268e-01 | 0.134 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 7.344418e-01 | 0.134 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.390463e-01 | 0.131 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 7.436075e-01 | 0.129 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 7.476737e-01 | 0.126 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.511813e-01 | 0.124 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 7.526100e-01 | 0.123 | 1 | 0 |
| Serine metabolism | R-HSA-977347 | 7.530247e-01 | 0.123 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.545586e-01 | 0.122 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.545586e-01 | 0.122 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.545586e-01 | 0.122 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.545586e-01 | 0.122 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.545586e-01 | 0.122 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.545586e-01 | 0.122 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.545586e-01 | 0.122 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.545586e-01 | 0.122 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.545586e-01 | 0.122 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.545586e-01 | 0.122 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.545586e-01 | 0.122 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.545586e-01 | 0.122 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.545586e-01 | 0.122 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.551384e-01 | 0.122 | 1 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.610642e-01 | 0.119 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.610642e-01 | 0.119 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.639667e-01 | 0.117 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.677845e-01 | 0.115 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.702277e-01 | 0.113 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.741366e-01 | 0.111 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.763644e-01 | 0.110 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.769694e-01 | 0.110 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.769694e-01 | 0.110 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.769694e-01 | 0.110 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.769694e-01 | 0.110 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.780003e-01 | 0.109 | 0 | 0 |
| Scavenging by Class H Receptors | R-HSA-3000497 | 7.780003e-01 | 0.109 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 7.780003e-01 | 0.109 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.780003e-01 | 0.109 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.780003e-01 | 0.109 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 7.780003e-01 | 0.109 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.780003e-01 | 0.109 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.780003e-01 | 0.109 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.780003e-01 | 0.109 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.780003e-01 | 0.109 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.782204e-01 | 0.109 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 7.782204e-01 | 0.109 | 1 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.782204e-01 | 0.109 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 7.782204e-01 | 0.109 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.782204e-01 | 0.109 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.790072e-01 | 0.108 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.808106e-01 | 0.107 | 1 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.870292e-01 | 0.104 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.870292e-01 | 0.104 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 7.870292e-01 | 0.104 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.870292e-01 | 0.104 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.870292e-01 | 0.104 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.889608e-01 | 0.103 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.890481e-01 | 0.103 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.917577e-01 | 0.101 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 7.926539e-01 | 0.101 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 7.926539e-01 | 0.101 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.963669e-01 | 0.099 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 7.971933e-01 | 0.098 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.988339e-01 | 0.098 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.992044e-01 | 0.097 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.992044e-01 | 0.097 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.992044e-01 | 0.097 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.992044e-01 | 0.097 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.992044e-01 | 0.097 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.992044e-01 | 0.097 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 7.992044e-01 | 0.097 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.992044e-01 | 0.097 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.992044e-01 | 0.097 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.992044e-01 | 0.097 | 0 | 0 |
| Gamma-carboxylation, transport, and amino-terminal cleavage of proteins | R-HSA-159854 | 7.992044e-01 | 0.097 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.992044e-01 | 0.097 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.992044e-01 | 0.097 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.992044e-01 | 0.097 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.992044e-01 | 0.097 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.992044e-01 | 0.097 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.992044e-01 | 0.097 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.992044e-01 | 0.097 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.992044e-01 | 0.097 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 8.004352e-01 | 0.097 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.004352e-01 | 0.097 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.006286e-01 | 0.097 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 8.022909e-01 | 0.096 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 8.022909e-01 | 0.096 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.022909e-01 | 0.096 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.024338e-01 | 0.096 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.024338e-01 | 0.096 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.045995e-01 | 0.094 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 8.155281e-01 | 0.089 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.167680e-01 | 0.088 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.168399e-01 | 0.088 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.168399e-01 | 0.088 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.168399e-01 | 0.088 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.183843e-01 | 0.087 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.183843e-01 | 0.087 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.183843e-01 | 0.087 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 8.183843e-01 | 0.087 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 8.183843e-01 | 0.087 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.183843e-01 | 0.087 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.183843e-01 | 0.087 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 8.183843e-01 | 0.087 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.183843e-01 | 0.087 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.201889e-01 | 0.086 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.221566e-01 | 0.085 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.242362e-01 | 0.084 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.277420e-01 | 0.082 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.291183e-01 | 0.081 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.294587e-01 | 0.081 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 8.302978e-01 | 0.081 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 8.302978e-01 | 0.081 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 8.302978e-01 | 0.081 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.321929e-01 | 0.080 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.357332e-01 | 0.078 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.357332e-01 | 0.078 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.357332e-01 | 0.078 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 8.357332e-01 | 0.078 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.357332e-01 | 0.078 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 8.357332e-01 | 0.078 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.357332e-01 | 0.078 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.357332e-01 | 0.078 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.357332e-01 | 0.078 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 8.357332e-01 | 0.078 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.357332e-01 | 0.078 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.357332e-01 | 0.078 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.357332e-01 | 0.078 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.373867e-01 | 0.077 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.376165e-01 | 0.077 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.391780e-01 | 0.076 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.391780e-01 | 0.076 | 1 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.417525e-01 | 0.075 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.428570e-01 | 0.074 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.428570e-01 | 0.074 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 8.428570e-01 | 0.074 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 8.428570e-01 | 0.074 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.453294e-01 | 0.073 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 8.468302e-01 | 0.072 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.468302e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 8.470378e-01 | 0.072 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.494673e-01 | 0.071 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 8.494673e-01 | 0.071 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 8.500585e-01 | 0.071 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.508498e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.508498e-01 | 0.070 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.514258e-01 | 0.070 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.514258e-01 | 0.070 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.514258e-01 | 0.070 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.514258e-01 | 0.070 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.514258e-01 | 0.070 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.514258e-01 | 0.070 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.514258e-01 | 0.070 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.514258e-01 | 0.070 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 8.514258e-01 | 0.070 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.514258e-01 | 0.070 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.514258e-01 | 0.070 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.514258e-01 | 0.070 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 8.514258e-01 | 0.070 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 8.514258e-01 | 0.070 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.514258e-01 | 0.070 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.514258e-01 | 0.070 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 8.532332e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 8.532332e-01 | 0.069 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 8.532332e-01 | 0.069 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.544750e-01 | 0.068 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.545665e-01 | 0.068 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.545665e-01 | 0.068 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 8.586960e-01 | 0.066 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.591783e-01 | 0.066 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.591783e-01 | 0.066 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 8.595981e-01 | 0.066 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.607848e-01 | 0.065 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.607848e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.629902e-01 | 0.064 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.642503e-01 | 0.063 | 1 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.654739e-01 | 0.063 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 8.654739e-01 | 0.063 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.654739e-01 | 0.063 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.654739e-01 | 0.063 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.654739e-01 | 0.063 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.654739e-01 | 0.063 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.656201e-01 | 0.063 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.656201e-01 | 0.063 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.656201e-01 | 0.063 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.656201e-01 | 0.063 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.656201e-01 | 0.063 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.660187e-01 | 0.062 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 8.660323e-01 | 0.062 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 8.660323e-01 | 0.062 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.660957e-01 | 0.062 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.683354e-01 | 0.061 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.683354e-01 | 0.061 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 8.683354e-01 | 0.061 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.683354e-01 | 0.061 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.683354e-01 | 0.061 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.687834e-01 | 0.061 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 8.701189e-01 | 0.060 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.720833e-01 | 0.059 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 8.724694e-01 | 0.059 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.724930e-01 | 0.059 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.724930e-01 | 0.059 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 8.736807e-01 | 0.059 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.739929e-01 | 0.058 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.756255e-01 | 0.058 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.756255e-01 | 0.058 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.756255e-01 | 0.058 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.756255e-01 | 0.058 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.756255e-01 | 0.058 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 8.780400e-01 | 0.056 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.784590e-01 | 0.056 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.784590e-01 | 0.056 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.784590e-01 | 0.056 | 0 | 0 |
| Scavenging by Class B Receptors | R-HSA-3000471 | 8.784590e-01 | 0.056 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.784590e-01 | 0.056 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.784590e-01 | 0.056 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.784590e-01 | 0.056 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.784590e-01 | 0.056 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.784590e-01 | 0.056 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.784590e-01 | 0.056 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.784590e-01 | 0.056 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.784590e-01 | 0.056 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.787561e-01 | 0.056 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.829193e-01 | 0.054 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 8.829193e-01 | 0.054 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.850662e-01 | 0.053 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.850662e-01 | 0.053 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.850662e-01 | 0.053 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 8.850844e-01 | 0.053 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.850844e-01 | 0.053 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.850844e-01 | 0.053 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 8.900720e-01 | 0.051 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.900720e-01 | 0.051 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.900720e-01 | 0.051 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.900720e-01 | 0.051 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.900720e-01 | 0.051 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.900720e-01 | 0.051 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.900720e-01 | 0.051 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.900720e-01 | 0.051 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.924516e-01 | 0.049 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.927239e-01 | 0.049 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 8.927239e-01 | 0.049 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 8.927239e-01 | 0.049 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 8.938391e-01 | 0.049 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.938391e-01 | 0.049 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.938391e-01 | 0.049 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.940847e-01 | 0.049 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.940847e-01 | 0.049 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 8.955008e-01 | 0.048 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.965768e-01 | 0.047 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.999044e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 8.999044e-01 | 0.046 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.999044e-01 | 0.046 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.999044e-01 | 0.046 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.999044e-01 | 0.046 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.005760e-01 | 0.045 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.005760e-01 | 0.045 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.005760e-01 | 0.045 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.006761e-01 | 0.045 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 9.019855e-01 | 0.045 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.019855e-01 | 0.045 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.019855e-01 | 0.045 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.022178e-01 | 0.045 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 9.022627e-01 | 0.045 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.028648e-01 | 0.044 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.038396e-01 | 0.044 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.056317e-01 | 0.043 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.066485e-01 | 0.043 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.066485e-01 | 0.043 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 9.066485e-01 | 0.043 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.067980e-01 | 0.042 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.077893e-01 | 0.042 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.085545e-01 | 0.042 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.095451e-01 | 0.041 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 9.095451e-01 | 0.041 | 1 | 1 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.095451e-01 | 0.041 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.095451e-01 | 0.041 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.095451e-01 | 0.041 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.100769e-01 | 0.041 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 9.100769e-01 | 0.041 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.100769e-01 | 0.041 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.100769e-01 | 0.041 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.100769e-01 | 0.041 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.100769e-01 | 0.041 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.103744e-01 | 0.041 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.128229e-01 | 0.040 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.129783e-01 | 0.040 | 1 | 1 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.144337e-01 | 0.039 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.144337e-01 | 0.039 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.156404e-01 | 0.038 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.156404e-01 | 0.038 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.165556e-01 | 0.038 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.165556e-01 | 0.038 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 9.165556e-01 | 0.038 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.165556e-01 | 0.038 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.165556e-01 | 0.038 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.165556e-01 | 0.038 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.165556e-01 | 0.038 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.165556e-01 | 0.038 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.170392e-01 | 0.038 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.180929e-01 | 0.037 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.186704e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.186704e-01 | 0.037 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.186704e-01 | 0.037 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.186704e-01 | 0.037 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.186704e-01 | 0.037 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.186704e-01 | 0.037 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 9.186704e-01 | 0.037 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.186704e-01 | 0.037 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.186704e-01 | 0.037 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.189153e-01 | 0.037 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 9.189153e-01 | 0.037 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.197439e-01 | 0.036 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.221635e-01 | 0.035 | 1 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.230529e-01 | 0.035 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.230529e-01 | 0.035 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.230529e-01 | 0.035 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.230529e-01 | 0.035 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.230529e-01 | 0.035 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.230529e-01 | 0.035 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.230529e-01 | 0.035 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.244800e-01 | 0.034 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.244800e-01 | 0.034 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.244800e-01 | 0.034 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.258300e-01 | 0.033 | 1 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.264431e-01 | 0.033 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 9.264431e-01 | 0.033 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 9.264431e-01 | 0.033 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 9.264431e-01 | 0.033 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.264431e-01 | 0.033 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.264431e-01 | 0.033 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.264431e-01 | 0.033 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.264431e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.269421e-01 | 0.033 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.269421e-01 | 0.033 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.273499e-01 | 0.033 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.290710e-01 | 0.032 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.290710e-01 | 0.032 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.290710e-01 | 0.032 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.290710e-01 | 0.032 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.290710e-01 | 0.032 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.291516e-01 | 0.032 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.296927e-01 | 0.032 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.304077e-01 | 0.031 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 9.304077e-01 | 0.031 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.315037e-01 | 0.031 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.321967e-01 | 0.030 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.334734e-01 | 0.030 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.334734e-01 | 0.030 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.334734e-01 | 0.030 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 9.334734e-01 | 0.030 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.334734e-01 | 0.030 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.334734e-01 | 0.030 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.334734e-01 | 0.030 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 9.345725e-01 | 0.029 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.345927e-01 | 0.029 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.346421e-01 | 0.029 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.346421e-01 | 0.029 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.346421e-01 | 0.029 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.379363e-01 | 0.028 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.382272e-01 | 0.028 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.393527e-01 | 0.027 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 9.397966e-01 | 0.027 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.397966e-01 | 0.027 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.397966e-01 | 0.027 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.398321e-01 | 0.027 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.398321e-01 | 0.027 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.398321e-01 | 0.027 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.398321e-01 | 0.027 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.398321e-01 | 0.027 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.398321e-01 | 0.027 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.398321e-01 | 0.027 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.398321e-01 | 0.027 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.398321e-01 | 0.027 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.398321e-01 | 0.027 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.416808e-01 | 0.026 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.419231e-01 | 0.026 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.445634e-01 | 0.025 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.445634e-01 | 0.025 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.445634e-01 | 0.025 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.455834e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.455834e-01 | 0.024 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.455834e-01 | 0.024 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.455834e-01 | 0.024 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.455834e-01 | 0.024 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.473968e-01 | 0.023 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.486202e-01 | 0.023 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.489693e-01 | 0.023 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.489693e-01 | 0.023 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.489693e-01 | 0.023 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.489693e-01 | 0.023 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.494056e-01 | 0.023 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.507853e-01 | 0.022 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.507853e-01 | 0.022 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.507853e-01 | 0.022 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.507853e-01 | 0.022 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.507853e-01 | 0.022 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.507853e-01 | 0.022 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 9.507853e-01 | 0.022 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 9.507853e-01 | 0.022 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.510295e-01 | 0.022 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.511233e-01 | 0.022 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.526292e-01 | 0.021 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.526292e-01 | 0.021 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.526760e-01 | 0.021 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.528436e-01 | 0.021 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.530399e-01 | 0.021 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.530399e-01 | 0.021 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.530399e-01 | 0.021 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.538317e-01 | 0.021 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.546023e-01 | 0.020 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.554901e-01 | 0.020 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.554901e-01 | 0.020 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.554901e-01 | 0.020 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.554901e-01 | 0.020 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.554901e-01 | 0.020 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.556251e-01 | 0.020 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.557261e-01 | 0.020 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.567988e-01 | 0.019 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.567988e-01 | 0.019 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.567988e-01 | 0.019 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 9.597455e-01 | 0.018 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.597455e-01 | 0.018 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 9.597455e-01 | 0.018 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.602686e-01 | 0.018 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.602686e-01 | 0.018 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.602686e-01 | 0.018 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.602686e-01 | 0.018 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.602686e-01 | 0.018 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.613897e-01 | 0.017 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.629440e-01 | 0.016 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.632590e-01 | 0.016 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.634700e-01 | 0.016 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.635942e-01 | 0.016 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.635942e-01 | 0.016 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.635942e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.635942e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.635942e-01 | 0.016 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.635942e-01 | 0.016 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.635942e-01 | 0.016 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.635942e-01 | 0.016 | 1 | 1 |
| tRNA processing | R-HSA-72306 | 9.653639e-01 | 0.015 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.655514e-01 | 0.015 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.663278e-01 | 0.015 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.663345e-01 | 0.015 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.664228e-01 | 0.015 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.664228e-01 | 0.015 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.664228e-01 | 0.015 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.664228e-01 | 0.015 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.664228e-01 | 0.015 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.670752e-01 | 0.015 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.670752e-01 | 0.015 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.670752e-01 | 0.015 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.670752e-01 | 0.015 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.670752e-01 | 0.015 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.670752e-01 | 0.015 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.691451e-01 | 0.014 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.693153e-01 | 0.014 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.693335e-01 | 0.014 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.697325e-01 | 0.013 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 9.702235e-01 | 0.013 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.702235e-01 | 0.013 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.702235e-01 | 0.013 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.702235e-01 | 0.013 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.702235e-01 | 0.013 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.707020e-01 | 0.013 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.714360e-01 | 0.013 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.716540e-01 | 0.012 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.719083e-01 | 0.012 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.726814e-01 | 0.012 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.726814e-01 | 0.012 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.730709e-01 | 0.012 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.730709e-01 | 0.012 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.731787e-01 | 0.012 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.731787e-01 | 0.012 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.731787e-01 | 0.012 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.744243e-01 | 0.011 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.756462e-01 | 0.011 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.756462e-01 | 0.011 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 9.756462e-01 | 0.011 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.760942e-01 | 0.011 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.760942e-01 | 0.011 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.762699e-01 | 0.010 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.762699e-01 | 0.010 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.765388e-01 | 0.010 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.765923e-01 | 0.010 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.768231e-01 | 0.010 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.777952e-01 | 0.010 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.779754e-01 | 0.010 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.786929e-01 | 0.009 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.787561e-01 | 0.009 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.791497e-01 | 0.009 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.798579e-01 | 0.009 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.800819e-01 | 0.009 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 9.800819e-01 | 0.009 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.802457e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.806162e-01 | 0.009 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.806162e-01 | 0.009 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.808312e-01 | 0.008 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.815175e-01 | 0.008 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.815175e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.817494e-01 | 0.008 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.817943e-01 | 0.008 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 9.819871e-01 | 0.008 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.819871e-01 | 0.008 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.819871e-01 | 0.008 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.826867e-01 | 0.008 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.830789e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.837101e-01 | 0.007 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.837101e-01 | 0.007 | 1 | 1 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 9.837101e-01 | 0.007 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.837101e-01 | 0.007 | 0 | 0 |
| Translation | R-HSA-72766 | 9.841726e-01 | 0.007 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.843840e-01 | 0.007 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.845303e-01 | 0.007 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.852134e-01 | 0.006 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.852684e-01 | 0.006 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.852684e-01 | 0.006 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.854582e-01 | 0.006 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.855607e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.857384e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.864190e-01 | 0.006 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.864190e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.864190e-01 | 0.006 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.864294e-01 | 0.006 | 1 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 9.866520e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.866777e-01 | 0.006 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.866777e-01 | 0.006 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.873185e-01 | 0.006 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.879523e-01 | 0.005 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.879523e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.880065e-01 | 0.005 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.884629e-01 | 0.005 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.886560e-01 | 0.005 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.886560e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.886560e-01 | 0.005 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.889521e-01 | 0.005 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.889521e-01 | 0.005 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.889849e-01 | 0.005 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.891050e-01 | 0.005 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.891050e-01 | 0.005 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.899343e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.900307e-01 | 0.004 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.901475e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.901475e-01 | 0.004 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.907782e-01 | 0.004 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.910903e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.910903e-01 | 0.004 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.910983e-01 | 0.004 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.912471e-01 | 0.004 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.912718e-01 | 0.004 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.915529e-01 | 0.004 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.916078e-01 | 0.004 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.917016e-01 | 0.004 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.917114e-01 | 0.004 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.919429e-01 | 0.004 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.919429e-01 | 0.004 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.920328e-01 | 0.003 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.922638e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.927140e-01 | 0.003 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.927379e-01 | 0.003 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.929161e-01 | 0.003 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.934091e-01 | 0.003 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.934113e-01 | 0.003 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.934113e-01 | 0.003 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.934113e-01 | 0.003 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.934879e-01 | 0.003 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.934879e-01 | 0.003 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.935060e-01 | 0.003 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.936573e-01 | 0.003 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.940419e-01 | 0.003 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.940419e-01 | 0.003 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.940717e-01 | 0.003 | 1 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.945208e-01 | 0.002 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.945663e-01 | 0.002 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.946122e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.946122e-01 | 0.002 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.946464e-01 | 0.002 | 1 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.949291e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.951060e-01 | 0.002 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.951239e-01 | 0.002 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.951279e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.955943e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.961883e-01 | 0.002 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.963705e-01 | 0.002 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.966072e-01 | 0.001 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.967364e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.967424e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.968158e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.968158e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.968158e-01 | 0.001 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.970544e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.973364e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.975669e-01 | 0.001 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.975915e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.976227e-01 | 0.001 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.977559e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.977559e-01 | 0.001 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.977757e-01 | 0.001 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.978270e-01 | 0.001 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.978934e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.981429e-01 | 0.001 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.982194e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.982194e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.985217e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.985441e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.987503e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.987823e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.987823e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.987937e-01 | 0.001 | 1 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.988097e-01 | 0.001 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.988097e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.988513e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.989238e-01 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.989238e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.989838e-01 | 0.000 | 1 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.990269e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990269e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.990886e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992044e-01 | 0.000 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.993090e-01 | 0.000 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.993956e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.994231e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.994568e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.994683e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994683e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.994683e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.994808e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.995492e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.995863e-01 | 0.000 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.996447e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.996718e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.996788e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.996844e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997096e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.997461e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997504e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.997512e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.997738e-01 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.997890e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.998029e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.998414e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999042e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999292e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999360e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999488e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999488e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999679e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999684e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.999715e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999742e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999774e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999789e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999804e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.999817e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999861e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999868e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.999884e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999901e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999915e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999940e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999947e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999949e-01 | 0.000 | 1 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999958e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999970e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999982e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999988e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999990e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999995e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999996e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999997e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999997e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999998e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999998e-01 | 0.000 | 1 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.110223e-16 | 15.955 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.110223e-16 | 15.955 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.110223e-16 | 15.955 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.110223e-16 | 15.955 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 9.936496e-14 | 13.003 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.087663e-12 | 11.680 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.516234e-10 | 9.124 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.783512e-09 | 8.749 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.125993e-09 | 8.147 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.122621e-07 | 6.673 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.636254e-07 | 6.579 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 3.736737e-07 | 6.428 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.091078e-07 | 6.092 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.789753e-06 | 5.747 | 1 | 0 |
| rRNA processing | R-HSA-72312 | 3.286789e-05 | 4.483 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 4.372964e-05 | 4.359 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 5.195984e-05 | 4.284 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 6.536037e-05 | 4.185 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.534864e-05 | 4.123 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 8.350042e-05 | 4.078 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 1.335693e-04 | 3.874 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.059990e-04 | 3.686 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.220845e-04 | 3.653 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.578898e-04 | 3.589 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.036224e-04 | 3.518 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.846729e-04 | 3.546 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.846729e-04 | 3.546 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 2.693823e-04 | 3.570 | 1 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.309349e-04 | 3.480 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 4.566840e-04 | 3.340 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.420128e-04 | 3.266 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 6.823990e-04 | 3.166 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.109050e-04 | 3.091 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 9.386297e-04 | 3.028 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.109046e-03 | 2.955 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.126311e-03 | 2.948 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.100145e-03 | 2.959 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.533872e-03 | 2.814 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.614396e-03 | 2.792 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.816520e-03 | 2.741 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.652943e-03 | 2.437 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.652943e-03 | 2.437 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.652943e-03 | 2.437 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.652943e-03 | 2.437 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.357376e-03 | 2.474 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.742655e-03 | 2.562 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.174376e-03 | 2.498 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.418068e-03 | 2.466 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.781619e-03 | 2.556 | 1 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.078382e-03 | 2.512 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.970851e-03 | 2.527 | 1 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 4.162636e-03 | 2.381 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.047088e-03 | 2.297 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.972485e-03 | 2.303 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.848372e-03 | 2.164 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.766504e-03 | 2.170 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.880780e-03 | 2.162 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 7.419770e-03 | 2.130 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 7.419770e-03 | 2.130 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.086745e-03 | 2.150 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.737139e-03 | 2.059 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 9.211560e-03 | 2.036 | 1 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 9.605366e-03 | 2.017 | 0 | 0 |
| S Phase | R-HSA-69242 | 9.249946e-03 | 2.034 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.006652e-02 | 1.997 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.011428e-02 | 1.995 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.011428e-02 | 1.995 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.061349e-02 | 1.974 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 1.061349e-02 | 1.974 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.056076e-02 | 1.976 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.061349e-02 | 1.974 | 1 | 1 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.103636e-02 | 1.957 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.131864e-02 | 1.946 | 1 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.141496e-02 | 1.943 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 1.219030e-02 | 1.914 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.253917e-02 | 1.902 | 1 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.309790e-02 | 1.883 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.272800e-02 | 1.895 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 1.368918e-02 | 1.864 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 1.302424e-02 | 1.885 | 1 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 1.302424e-02 | 1.885 | 1 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 1.422077e-02 | 1.847 | 1 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.452009e-02 | 1.838 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.593404e-02 | 1.798 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 1.784913e-02 | 1.748 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.795054e-02 | 1.746 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.795054e-02 | 1.746 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.837957e-02 | 1.736 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.895158e-02 | 1.722 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.937942e-02 | 1.713 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.937942e-02 | 1.713 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.992081e-02 | 1.701 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 2.087445e-02 | 1.680 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 2.102808e-02 | 1.677 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 2.087445e-02 | 1.680 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.063252e-02 | 1.685 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.189755e-02 | 1.660 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.114906e-02 | 1.675 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 2.273763e-02 | 1.643 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.345084e-02 | 1.630 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 2.432292e-02 | 1.614 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.485833e-02 | 1.605 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.704048e-02 | 1.568 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.708813e-02 | 1.567 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.659125e-02 | 1.575 | 1 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 2.808504e-02 | 1.552 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.708813e-02 | 1.567 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.821372e-02 | 1.550 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.052236e-02 | 1.515 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 3.052236e-02 | 1.515 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.080795e-02 | 1.511 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 3.167891e-02 | 1.499 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 3.181103e-02 | 1.497 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 3.197729e-02 | 1.495 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 3.197729e-02 | 1.495 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.356597e-02 | 1.474 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.629614e-02 | 1.440 | 1 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 3.373985e-02 | 1.472 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 4.105611e-02 | 1.387 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.707623e-02 | 1.431 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.118013e-02 | 1.385 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.118013e-02 | 1.385 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.118013e-02 | 1.385 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.978180e-02 | 1.400 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.851628e-02 | 1.414 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.018818e-02 | 1.396 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.018818e-02 | 1.396 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 3.837033e-02 | 1.416 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 3.900406e-02 | 1.409 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.887699e-02 | 1.410 | 1 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.118013e-02 | 1.385 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.120031e-02 | 1.385 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 4.129820e-02 | 1.384 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 4.129820e-02 | 1.384 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 4.175313e-02 | 1.379 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 4.175313e-02 | 1.379 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.183135e-02 | 1.378 | 1 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.284539e-02 | 1.368 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.284539e-02 | 1.368 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.284539e-02 | 1.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.284539e-02 | 1.368 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.284539e-02 | 1.368 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.284539e-02 | 1.368 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 4.334287e-02 | 1.363 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.334287e-02 | 1.363 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.487741e-02 | 1.348 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.634732e-02 | 1.334 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.634732e-02 | 1.334 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.642926e-02 | 1.333 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 5.176801e-02 | 1.286 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.970654e-02 | 1.304 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 5.181751e-02 | 1.286 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 5.193761e-02 | 1.285 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 5.204500e-02 | 1.284 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 5.553551e-02 | 1.255 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.747696e-02 | 1.241 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.747696e-02 | 1.241 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 5.747696e-02 | 1.241 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.591745e-02 | 1.252 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.591745e-02 | 1.252 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.591745e-02 | 1.252 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.712597e-02 | 1.243 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.712597e-02 | 1.243 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.074064e-02 | 1.217 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.783950e-02 | 1.238 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 5.747696e-02 | 1.241 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.473284e-02 | 1.262 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.070944e-02 | 1.217 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.164433e-02 | 1.210 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 5.454433e-02 | 1.263 | 1 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 5.396061e-02 | 1.268 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 5.591745e-02 | 1.252 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.770451e-02 | 1.239 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.537839e-02 | 1.257 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 5.370438e-02 | 1.270 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.199249e-02 | 1.208 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 6.199249e-02 | 1.208 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 6.278586e-02 | 1.202 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 6.278586e-02 | 1.202 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 6.278586e-02 | 1.202 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 6.303480e-02 | 1.200 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 6.322370e-02 | 1.199 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 6.322370e-02 | 1.199 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 6.322370e-02 | 1.199 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 6.368493e-02 | 1.196 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 7.267773e-02 | 1.139 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.104082e-02 | 1.148 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.104082e-02 | 1.148 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 6.862589e-02 | 1.164 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 6.862589e-02 | 1.164 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.638429e-02 | 1.178 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.653481e-02 | 1.116 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.585390e-02 | 1.120 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 6.480154e-02 | 1.188 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.862589e-02 | 1.164 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 7.478023e-02 | 1.126 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.862589e-02 | 1.164 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 7.134742e-02 | 1.147 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 7.134742e-02 | 1.147 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.618888e-02 | 1.118 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 6.862589e-02 | 1.164 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 6.862589e-02 | 1.164 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 7.089134e-02 | 1.149 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.237389e-02 | 1.140 | 1 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 7.478023e-02 | 1.126 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 7.073635e-02 | 1.150 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.653481e-02 | 1.116 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.653481e-02 | 1.116 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.653481e-02 | 1.116 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.653481e-02 | 1.116 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 7.437632e-02 | 1.129 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.653481e-02 | 1.116 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.656436e-02 | 1.116 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 7.656436e-02 | 1.116 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 7.674280e-02 | 1.115 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.685437e-02 | 1.114 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.800201e-02 | 1.108 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 8.284879e-02 | 1.082 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 8.549928e-02 | 1.068 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 8.591720e-02 | 1.066 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.818347e-02 | 1.055 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 8.818347e-02 | 1.055 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.844990e-02 | 1.053 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 9.086836e-02 | 1.042 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.129085e-02 | 1.040 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 9.337884e-02 | 1.030 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 9.487739e-02 | 1.023 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.059817e-01 | 0.975 | 1 | 1 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.103132e-01 | 0.957 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.072721e-01 | 0.970 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.175132e-01 | 0.930 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.175132e-01 | 0.930 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 1.182194e-01 | 0.927 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.015639e-01 | 0.993 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.058394e-01 | 0.975 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.026267e-01 | 0.989 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 9.841573e-02 | 1.007 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.749058e-02 | 1.011 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 9.841573e-02 | 1.007 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 1.182194e-01 | 0.927 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.025191e-01 | 0.989 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 1.103132e-01 | 0.957 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.057730e-01 | 0.976 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.111323e-01 | 0.954 | 1 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.125780e-01 | 0.949 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.217320e-01 | 0.915 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.182194e-01 | 0.927 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 9.882966e-02 | 1.005 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 9.841573e-02 | 1.007 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.071344e-01 | 0.970 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 9.882966e-02 | 1.005 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.219983e-01 | 0.914 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.219983e-01 | 0.914 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.219983e-01 | 0.914 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 1.219983e-01 | 0.914 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.219983e-01 | 0.914 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.230604e-01 | 0.910 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 1.230604e-01 | 0.910 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.230604e-01 | 0.910 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.230604e-01 | 0.910 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.260758e-01 | 0.899 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.281974e-01 | 0.892 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.281974e-01 | 0.892 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 1.308421e-01 | 0.883 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.382634e-01 | 0.859 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.388313e-01 | 0.858 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.388313e-01 | 0.858 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.393063e-01 | 0.856 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.400774e-01 | 0.854 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.400774e-01 | 0.854 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.400774e-01 | 0.854 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.400774e-01 | 0.854 | 0 | 0 |
| UNC93B1 deficiency - HSE | R-HSA-5602415 | 1.400774e-01 | 0.854 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.400774e-01 | 0.854 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.400774e-01 | 0.854 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.400774e-01 | 0.854 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.400774e-01 | 0.854 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.485309e-01 | 0.828 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.749332e-01 | 0.757 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.563923e-01 | 0.806 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.495019e-01 | 0.825 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.781696e-01 | 0.749 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.508202e-01 | 0.822 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.508202e-01 | 0.822 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.749776e-01 | 0.757 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.749776e-01 | 0.757 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.720822e-01 | 0.764 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.727935e-01 | 0.762 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.727935e-01 | 0.762 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.784213e-01 | 0.749 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.784213e-01 | 0.749 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.406320e-01 | 0.852 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.630395e-01 | 0.788 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.801327e-01 | 0.744 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.639868e-01 | 0.785 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.639868e-01 | 0.785 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 1.745934e-01 | 0.758 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.563923e-01 | 0.806 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.720822e-01 | 0.764 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 1.749332e-01 | 0.757 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.802648e-01 | 0.744 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 1.720822e-01 | 0.764 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.485309e-01 | 0.828 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.745934e-01 | 0.758 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.692193e-01 | 0.772 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.482706e-01 | 0.829 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.749776e-01 | 0.757 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.749776e-01 | 0.757 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.749776e-01 | 0.757 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.745934e-01 | 0.758 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.508148e-01 | 0.822 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.749332e-01 | 0.757 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.749332e-01 | 0.757 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.749332e-01 | 0.757 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.716147e-01 | 0.765 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 1.409370e-01 | 0.851 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.805136e-01 | 0.743 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.863558e-01 | 0.730 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 1.875757e-01 | 0.727 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.875757e-01 | 0.727 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 1.933478e-01 | 0.714 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.933478e-01 | 0.714 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.933478e-01 | 0.714 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 1.933478e-01 | 0.714 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 1.933478e-01 | 0.714 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 1.942108e-01 | 0.712 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.025821e-01 | 0.693 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 2.025821e-01 | 0.693 | 0 | 0 |
| Defective SLC12A6 causes agenesis of the corpus callosum, with peripheral neuropathy (ACCPN) | R-HSA-5619039 | 2.025821e-01 | 0.693 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.025821e-01 | 0.693 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.025821e-01 | 0.693 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.605470e-01 | 0.584 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.143017e-01 | 0.503 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.143017e-01 | 0.503 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 3.143017e-01 | 0.503 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 3.143017e-01 | 0.503 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.294890e-01 | 0.639 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 3.641516e-01 | 0.439 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.125707e-01 | 0.672 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 4.103802e-01 | 0.387 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 4.103802e-01 | 0.387 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 4.103802e-01 | 0.387 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.520968e-01 | 0.598 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.520968e-01 | 0.598 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.722462e-01 | 0.565 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 3.400209e-01 | 0.468 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 3.400209e-01 | 0.468 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 3.400209e-01 | 0.468 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.532503e-01 | 0.344 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 4.532503e-01 | 0.344 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.532503e-01 | 0.344 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 4.532503e-01 | 0.344 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 4.532503e-01 | 0.344 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.136919e-01 | 0.670 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.670816e-01 | 0.435 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 3.129623e-01 | 0.505 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 2.728191e-01 | 0.564 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.144464e-01 | 0.669 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 4.930059e-01 | 0.307 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.005173e-01 | 0.698 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 3.943393e-01 | 0.404 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.298729e-01 | 0.276 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.712072e-01 | 0.567 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.737377e-01 | 0.427 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.926079e-01 | 0.534 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 3.130417e-01 | 0.504 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.857185e-01 | 0.414 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.857185e-01 | 0.414 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.004613e-01 | 0.397 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 4.943535e-01 | 0.306 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 4.943535e-01 | 0.306 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 5.640611e-01 | 0.249 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 5.640611e-01 | 0.249 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 5.178259e-01 | 0.286 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 4.071565e-01 | 0.390 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.732198e-01 | 0.325 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 5.405605e-01 | 0.267 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 5.957650e-01 | 0.225 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 5.957650e-01 | 0.225 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.874601e-01 | 0.312 | 1 | 1 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.874601e-01 | 0.312 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.874601e-01 | 0.312 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 5.054709e-01 | 0.296 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 5.054709e-01 | 0.296 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 5.054709e-01 | 0.296 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.287868e-01 | 0.277 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 4.595715e-01 | 0.338 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 4.595715e-01 | 0.338 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.155085e-01 | 0.288 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.365658e-01 | 0.270 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.292906e-01 | 0.276 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 5.837553e-01 | 0.234 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 5.837553e-01 | 0.234 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.666454e-01 | 0.247 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.666454e-01 | 0.247 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.666454e-01 | 0.247 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.811283e-01 | 0.236 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 5.812735e-01 | 0.236 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 5.977356e-01 | 0.223 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 5.977356e-01 | 0.223 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 3.129623e-01 | 0.505 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.729912e-01 | 0.325 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.244902e-01 | 0.372 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.831862e-01 | 0.548 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 3.121387e-01 | 0.506 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 3.407851e-01 | 0.468 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.857185e-01 | 0.414 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.857185e-01 | 0.414 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.857185e-01 | 0.414 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.472047e-01 | 0.262 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 5.957650e-01 | 0.225 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.577237e-01 | 0.254 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.831862e-01 | 0.548 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.640611e-01 | 0.249 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.734812e-01 | 0.325 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.004887e-01 | 0.698 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.074281e-01 | 0.390 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 2.294890e-01 | 0.639 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 3.641516e-01 | 0.439 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.641516e-01 | 0.439 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 3.126100e-01 | 0.505 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.400209e-01 | 0.468 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 4.532503e-01 | 0.344 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 2.271605e-01 | 0.644 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 5.640611e-01 | 0.249 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.491148e-01 | 0.457 | 1 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.376066e-01 | 0.359 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.727569e-01 | 0.564 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.126100e-01 | 0.505 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 3.400209e-01 | 0.468 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 5.625405e-01 | 0.250 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.271605e-01 | 0.644 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.624460e-01 | 0.581 | 1 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 4.571954e-01 | 0.340 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.510100e-01 | 0.455 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.271605e-01 | 0.644 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 2.849602e-01 | 0.545 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.103802e-01 | 0.387 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.321799e-01 | 0.634 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.398991e-01 | 0.469 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 2.015670e-01 | 0.696 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.298729e-01 | 0.276 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.709563e-01 | 0.431 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.857185e-01 | 0.414 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.151648e-01 | 0.382 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 5.957650e-01 | 0.225 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 4.269842e-01 | 0.370 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 5.977356e-01 | 0.223 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.571954e-01 | 0.340 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 4.734812e-01 | 0.325 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.727569e-01 | 0.564 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.143636e-01 | 0.383 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.202429e-01 | 0.376 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.341712e-01 | 0.362 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.709563e-01 | 0.431 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 2.019977e-01 | 0.695 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.103802e-01 | 0.387 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.103802e-01 | 0.387 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.532503e-01 | 0.344 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 4.930059e-01 | 0.307 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 4.930059e-01 | 0.307 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.230027e-01 | 0.491 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.197926e-01 | 0.377 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 3.090976e-01 | 0.510 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.995164e-01 | 0.398 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 4.571954e-01 | 0.340 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.334351e-01 | 0.363 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 5.957650e-01 | 0.225 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.695322e-01 | 0.244 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 2.728191e-01 | 0.564 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.515701e-01 | 0.258 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 3.129623e-01 | 0.505 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.130417e-01 | 0.504 | 1 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 3.752256e-01 | 0.426 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 5.666454e-01 | 0.247 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 4.755691e-01 | 0.323 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 3.090976e-01 | 0.510 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.151648e-01 | 0.382 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.977356e-01 | 0.223 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.894264e-01 | 0.538 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 5.957650e-01 | 0.225 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.403135e-01 | 0.356 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 5.405605e-01 | 0.267 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 5.625405e-01 | 0.250 | 1 | 1 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.956305e-01 | 0.305 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.197926e-01 | 0.377 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.185495e-01 | 0.497 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 3.143017e-01 | 0.503 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 3.641516e-01 | 0.439 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.125707e-01 | 0.672 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 4.532503e-01 | 0.344 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.004887e-01 | 0.698 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.936983e-01 | 0.405 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 2.005173e-01 | 0.698 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.538096e-01 | 0.451 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.682832e-01 | 0.571 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.015554e-01 | 0.521 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.568217e-01 | 0.448 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.943393e-01 | 0.404 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 5.298729e-01 | 0.276 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 5.298729e-01 | 0.276 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.298729e-01 | 0.276 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 4.729912e-01 | 0.325 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.178259e-01 | 0.286 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.178259e-01 | 0.286 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.178259e-01 | 0.286 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 5.405605e-01 | 0.267 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 4.407359e-01 | 0.356 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.015608e-01 | 0.300 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 5.837553e-01 | 0.234 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 4.983591e-01 | 0.302 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.341712e-01 | 0.362 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 5.977356e-01 | 0.223 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 5.178259e-01 | 0.286 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.695322e-01 | 0.244 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.976047e-01 | 0.526 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 4.407427e-01 | 0.356 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 3.754943e-01 | 0.425 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 5.977356e-01 | 0.223 | 1 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 2.294890e-01 | 0.639 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.408695e-01 | 0.618 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 4.930059e-01 | 0.307 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 3.587479e-01 | 0.445 | 1 | 0 |
| G2/M Transition | R-HSA-69275 | 2.137890e-01 | 0.670 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.741395e-01 | 0.427 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.629295e-01 | 0.580 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.472955e-01 | 0.262 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.255647e-01 | 0.647 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 5.266435e-01 | 0.278 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.105467e-01 | 0.292 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 2.849602e-01 | 0.545 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.547936e-01 | 0.594 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.197926e-01 | 0.377 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.103802e-01 | 0.387 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.837553e-01 | 0.234 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 2.831862e-01 | 0.548 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 2.831862e-01 | 0.548 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.070120e-01 | 0.390 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.919405e-01 | 0.308 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.811283e-01 | 0.236 | 1 | 1 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.501941e-01 | 0.456 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 2.019977e-01 | 0.695 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 2.572023e-01 | 0.590 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.125707e-01 | 0.672 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.126100e-01 | 0.505 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.341712e-01 | 0.362 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 4.943535e-01 | 0.306 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.105467e-01 | 0.292 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.640930e-01 | 0.249 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.837553e-01 | 0.234 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.943393e-01 | 0.404 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.737377e-01 | 0.427 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 2.927205e-01 | 0.534 | 1 | 1 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 2.200627e-01 | 0.657 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.943535e-01 | 0.306 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.282819e-01 | 0.368 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.178259e-01 | 0.286 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.716382e-01 | 0.243 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.436961e-01 | 0.613 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.294890e-01 | 0.639 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.333992e-01 | 0.477 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.930059e-01 | 0.307 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.129232e-01 | 0.672 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.798057e-01 | 0.553 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.906163e-01 | 0.408 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 4.537249e-01 | 0.343 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.129623e-01 | 0.505 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.520968e-01 | 0.598 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.906163e-01 | 0.408 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 2.520968e-01 | 0.598 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 5.419513e-01 | 0.266 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.995164e-01 | 0.398 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 2.572023e-01 | 0.590 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.103802e-01 | 0.387 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.103802e-01 | 0.387 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.084980e-01 | 0.681 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 4.197926e-01 | 0.377 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 2.976047e-01 | 0.526 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 5.298729e-01 | 0.276 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.640611e-01 | 0.249 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 5.640611e-01 | 0.249 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 4.038284e-01 | 0.394 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 5.957650e-01 | 0.225 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.287868e-01 | 0.277 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.360670e-01 | 0.271 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 5.532591e-01 | 0.257 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.341712e-01 | 0.362 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.919405e-01 | 0.308 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 4.909504e-01 | 0.309 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.895794e-01 | 0.310 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.841362e-01 | 0.233 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 2.639396e-01 | 0.578 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 3.943393e-01 | 0.404 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 3.943393e-01 | 0.404 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 3.230027e-01 | 0.491 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 4.452997e-01 | 0.351 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 5.957650e-01 | 0.225 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.449566e-01 | 0.611 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 3.121387e-01 | 0.506 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 3.709563e-01 | 0.431 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.894264e-01 | 0.538 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.538096e-01 | 0.451 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.537249e-01 | 0.343 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.857185e-01 | 0.414 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.294890e-01 | 0.639 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.294890e-01 | 0.639 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.294890e-01 | 0.639 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 2.849602e-01 | 0.545 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.532503e-01 | 0.344 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 4.532503e-01 | 0.344 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 4.930059e-01 | 0.307 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.197926e-01 | 0.377 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 4.197926e-01 | 0.377 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.400113e-01 | 0.620 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 5.105467e-01 | 0.292 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 4.719264e-01 | 0.326 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 5.625405e-01 | 0.250 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.625405e-01 | 0.250 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.837553e-01 | 0.234 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.843482e-01 | 0.233 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.143636e-01 | 0.383 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.843482e-01 | 0.233 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.401572e-01 | 0.620 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 5.811283e-01 | 0.236 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.539892e-01 | 0.451 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 5.211383e-01 | 0.283 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 2.294890e-01 | 0.639 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 2.849602e-01 | 0.545 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 5.640611e-01 | 0.249 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 5.178259e-01 | 0.286 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 5.405605e-01 | 0.267 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.282819e-01 | 0.368 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.126100e-01 | 0.505 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.537249e-01 | 0.343 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 5.640611e-01 | 0.249 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 5.405605e-01 | 0.267 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.748348e-01 | 0.561 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.298729e-01 | 0.276 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.241455e-01 | 0.372 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 5.105467e-01 | 0.292 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.818539e-01 | 0.550 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.452997e-01 | 0.351 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 5.178259e-01 | 0.286 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 5.405605e-01 | 0.267 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 5.640930e-01 | 0.249 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 3.670816e-01 | 0.435 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.370505e-01 | 0.625 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 4.943535e-01 | 0.306 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 5.977356e-01 | 0.223 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 4.726462e-01 | 0.325 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 3.936983e-01 | 0.405 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 5.405605e-01 | 0.267 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.864201e-01 | 0.232 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 5.977356e-01 | 0.223 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.812735e-01 | 0.236 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 4.452997e-01 | 0.351 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 4.571954e-01 | 0.340 | 1 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.986985e-01 | 0.223 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.042001e-01 | 0.219 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.074962e-01 | 0.216 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.079197e-01 | 0.216 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 6.079197e-01 | 0.216 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 6.079197e-01 | 0.216 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.079197e-01 | 0.216 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.139059e-01 | 0.212 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.139059e-01 | 0.212 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.184592e-01 | 0.209 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.202677e-01 | 0.207 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.233958e-01 | 0.205 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 6.233958e-01 | 0.205 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 6.233958e-01 | 0.205 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 6.233958e-01 | 0.205 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 6.238746e-01 | 0.205 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 6.238746e-01 | 0.205 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.238746e-01 | 0.205 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.251650e-01 | 0.204 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.251650e-01 | 0.204 | 1 | 1 |
| DNA replication initiation | R-HSA-68952 | 6.251650e-01 | 0.204 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 6.251650e-01 | 0.204 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.251650e-01 | 0.204 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.251650e-01 | 0.204 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.251650e-01 | 0.204 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 6.251650e-01 | 0.204 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 6.251650e-01 | 0.204 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 6.251650e-01 | 0.204 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.251650e-01 | 0.204 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 6.251650e-01 | 0.204 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 6.251650e-01 | 0.204 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 6.276931e-01 | 0.202 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 6.286462e-01 | 0.202 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.296322e-01 | 0.201 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.296322e-01 | 0.201 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 6.371884e-01 | 0.196 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 6.376923e-01 | 0.195 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.376923e-01 | 0.195 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 6.427827e-01 | 0.192 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.427827e-01 | 0.192 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 6.427827e-01 | 0.192 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 6.427827e-01 | 0.192 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 6.442568e-01 | 0.191 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 6.449098e-01 | 0.191 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.454816e-01 | 0.190 | 1 | 0 |
| L1CAM interactions | R-HSA-373760 | 6.460942e-01 | 0.190 | 1 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.524283e-01 | 0.185 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.524283e-01 | 0.185 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.524283e-01 | 0.185 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.524283e-01 | 0.185 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.524283e-01 | 0.185 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 6.524283e-01 | 0.185 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 6.524283e-01 | 0.185 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 6.524283e-01 | 0.185 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 6.524283e-01 | 0.185 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 6.524283e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 6.524283e-01 | 0.185 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 6.524283e-01 | 0.185 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 6.524283e-01 | 0.185 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.533246e-01 | 0.185 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 6.597358e-01 | 0.181 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 6.609071e-01 | 0.180 | 1 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 6.609319e-01 | 0.180 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 6.609319e-01 | 0.180 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 6.609319e-01 | 0.180 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 6.609319e-01 | 0.180 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 6.609319e-01 | 0.180 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.613752e-01 | 0.180 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.627333e-01 | 0.179 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.627333e-01 | 0.179 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.744102e-01 | 0.171 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.744737e-01 | 0.171 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.748091e-01 | 0.171 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.777102e-01 | 0.169 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 6.777102e-01 | 0.169 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 6.777102e-01 | 0.169 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 6.777102e-01 | 0.169 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 6.777102e-01 | 0.169 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.777102e-01 | 0.169 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 6.777102e-01 | 0.169 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 6.777102e-01 | 0.169 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 6.777102e-01 | 0.169 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 6.777102e-01 | 0.169 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 6.777102e-01 | 0.169 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 6.777102e-01 | 0.169 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 6.777102e-01 | 0.169 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.783323e-01 | 0.169 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.783323e-01 | 0.169 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.784099e-01 | 0.169 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.877544e-01 | 0.163 | 1 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 6.880292e-01 | 0.162 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 6.880292e-01 | 0.162 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 6.949970e-01 | 0.158 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.949970e-01 | 0.158 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.949970e-01 | 0.158 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 6.949970e-01 | 0.158 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.949970e-01 | 0.158 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.963298e-01 | 0.157 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 7.007257e-01 | 0.154 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 7.011545e-01 | 0.154 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.011545e-01 | 0.154 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.011545e-01 | 0.154 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.011545e-01 | 0.154 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.011545e-01 | 0.154 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.011545e-01 | 0.154 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 7.011545e-01 | 0.154 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 7.011545e-01 | 0.154 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 7.011545e-01 | 0.154 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.011545e-01 | 0.154 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 7.011545e-01 | 0.154 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 7.011545e-01 | 0.154 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.014987e-01 | 0.154 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.014987e-01 | 0.154 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 7.053091e-01 | 0.152 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.103012e-01 | 0.149 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.103012e-01 | 0.149 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.103012e-01 | 0.149 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 7.106787e-01 | 0.148 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 7.106787e-01 | 0.148 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.109408e-01 | 0.148 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 7.109408e-01 | 0.148 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.109408e-01 | 0.148 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 7.109408e-01 | 0.148 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.109408e-01 | 0.148 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.137064e-01 | 0.146 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 7.141110e-01 | 0.146 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.145203e-01 | 0.146 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 7.145203e-01 | 0.146 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.166992e-01 | 0.145 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.218533e-01 | 0.142 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.221131e-01 | 0.141 | 1 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.228947e-01 | 0.141 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 7.228947e-01 | 0.141 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.228947e-01 | 0.141 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.228947e-01 | 0.141 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.228947e-01 | 0.141 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.228947e-01 | 0.141 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.246405e-01 | 0.140 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 7.261805e-01 | 0.139 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.261805e-01 | 0.139 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.261805e-01 | 0.139 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 7.280332e-01 | 0.138 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.290278e-01 | 0.137 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.300857e-01 | 0.137 | 1 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.302891e-01 | 0.137 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 7.311752e-01 | 0.136 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 7.311786e-01 | 0.136 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 7.330738e-01 | 0.135 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 7.344887e-01 | 0.134 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.389596e-01 | 0.131 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.392373e-01 | 0.131 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.392373e-01 | 0.131 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.392373e-01 | 0.131 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 7.393493e-01 | 0.131 | 1 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.407340e-01 | 0.130 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 7.407340e-01 | 0.130 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 7.407340e-01 | 0.130 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.430546e-01 | 0.129 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 7.430546e-01 | 0.129 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.430546e-01 | 0.129 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.430546e-01 | 0.129 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 7.430546e-01 | 0.129 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.430546e-01 | 0.129 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.430546e-01 | 0.129 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.432349e-01 | 0.129 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.497359e-01 | 0.125 | 1 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.509440e-01 | 0.124 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 7.509440e-01 | 0.124 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.534463e-01 | 0.123 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 7.534463e-01 | 0.123 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.546206e-01 | 0.122 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.583652e-01 | 0.120 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 7.617489e-01 | 0.118 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.617489e-01 | 0.118 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 7.617489e-01 | 0.118 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.617489e-01 | 0.118 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.617489e-01 | 0.118 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 7.617489e-01 | 0.118 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 7.617489e-01 | 0.118 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.622249e-01 | 0.118 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.622249e-01 | 0.118 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.622249e-01 | 0.118 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.633379e-01 | 0.117 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 7.677821e-01 | 0.115 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.678601e-01 | 0.115 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.678601e-01 | 0.115 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 7.706429e-01 | 0.113 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 7.723583e-01 | 0.112 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.729257e-01 | 0.112 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.746849e-01 | 0.111 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.758271e-01 | 0.110 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.790842e-01 | 0.108 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 7.790842e-01 | 0.108 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.790842e-01 | 0.108 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 7.790842e-01 | 0.108 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.790842e-01 | 0.108 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.790842e-01 | 0.108 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.801884e-01 | 0.108 | 0 | 0 |
| Protein folding | R-HSA-391251 | 7.801884e-01 | 0.108 | 1 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 7.804733e-01 | 0.108 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.804733e-01 | 0.108 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 7.804733e-01 | 0.108 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.822013e-01 | 0.107 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.835404e-01 | 0.106 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 7.835404e-01 | 0.106 | 1 | 1 |
| Signaling by ROBO receptors | R-HSA-376176 | 7.840143e-01 | 0.106 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.841216e-01 | 0.106 | 1 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 7.841875e-01 | 0.106 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.841875e-01 | 0.106 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 7.923043e-01 | 0.101 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 7.924811e-01 | 0.101 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 7.924811e-01 | 0.101 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.924811e-01 | 0.101 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.924811e-01 | 0.101 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.924811e-01 | 0.101 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.935917e-01 | 0.100 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.935917e-01 | 0.100 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.935917e-01 | 0.100 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.951590e-01 | 0.100 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 7.951590e-01 | 0.100 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.951590e-01 | 0.100 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 7.951590e-01 | 0.100 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 7.951590e-01 | 0.100 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.951590e-01 | 0.100 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 7.951590e-01 | 0.100 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.001804e-01 | 0.097 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.032999e-01 | 0.095 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.039048e-01 | 0.095 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.039048e-01 | 0.095 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 8.039048e-01 | 0.095 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.094774e-01 | 0.092 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 8.100651e-01 | 0.091 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.100651e-01 | 0.091 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.100651e-01 | 0.091 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.100651e-01 | 0.091 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 8.100651e-01 | 0.091 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.100651e-01 | 0.091 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 8.147659e-01 | 0.089 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.147659e-01 | 0.089 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.147659e-01 | 0.089 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.163023e-01 | 0.088 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.214302e-01 | 0.085 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.214302e-01 | 0.085 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.214302e-01 | 0.085 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 8.229333e-01 | 0.085 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 8.238874e-01 | 0.084 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.238874e-01 | 0.084 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 8.238874e-01 | 0.084 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.250856e-01 | 0.084 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.250856e-01 | 0.084 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.250856e-01 | 0.084 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.250856e-01 | 0.084 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.252486e-01 | 0.083 | 0 | 0 |
| Translation | R-HSA-72766 | 8.282806e-01 | 0.082 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.299702e-01 | 0.081 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.316577e-01 | 0.080 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.348853e-01 | 0.078 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.348853e-01 | 0.078 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.360707e-01 | 0.078 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.367044e-01 | 0.077 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.367044e-01 | 0.077 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.367044e-01 | 0.077 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 8.367044e-01 | 0.077 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.369166e-01 | 0.077 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.381573e-01 | 0.077 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 8.389189e-01 | 0.076 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 8.389189e-01 | 0.076 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.423010e-01 | 0.075 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.441859e-01 | 0.074 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.441859e-01 | 0.074 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.441859e-01 | 0.074 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 8.441859e-01 | 0.074 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.475716e-01 | 0.072 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.485894e-01 | 0.071 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 8.485894e-01 | 0.071 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.485894e-01 | 0.071 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.485894e-01 | 0.071 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 8.485894e-01 | 0.071 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.485894e-01 | 0.071 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 8.485894e-01 | 0.071 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 8.495896e-01 | 0.071 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.526541e-01 | 0.069 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.530081e-01 | 0.069 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 8.530081e-01 | 0.069 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 8.550648e-01 | 0.068 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.596101e-01 | 0.066 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 8.596101e-01 | 0.066 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.596101e-01 | 0.066 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.596101e-01 | 0.066 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.596101e-01 | 0.066 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.607036e-01 | 0.065 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.607036e-01 | 0.065 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.613724e-01 | 0.065 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.613724e-01 | 0.065 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.634306e-01 | 0.064 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.641570e-01 | 0.063 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.665052e-01 | 0.062 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.665052e-01 | 0.062 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 8.683352e-01 | 0.061 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.692985e-01 | 0.061 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.692985e-01 | 0.061 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.692985e-01 | 0.061 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.693422e-01 | 0.061 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.693422e-01 | 0.061 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 8.698292e-01 | 0.061 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.719850e-01 | 0.059 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.768059e-01 | 0.057 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.768059e-01 | 0.057 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.768059e-01 | 0.057 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.768059e-01 | 0.057 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.792185e-01 | 0.056 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 8.793050e-01 | 0.056 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.804447e-01 | 0.055 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.804447e-01 | 0.055 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 8.827008e-01 | 0.054 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.839136e-01 | 0.054 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 8.839136e-01 | 0.054 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.839136e-01 | 0.054 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.839136e-01 | 0.054 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 8.839136e-01 | 0.054 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.839136e-01 | 0.054 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 8.839136e-01 | 0.054 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 8.880267e-01 | 0.052 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.880916e-01 | 0.052 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 8.880916e-01 | 0.052 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.880916e-01 | 0.052 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 8.906400e-01 | 0.050 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 8.907263e-01 | 0.050 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.936396e-01 | 0.049 | 1 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.962389e-01 | 0.048 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.962389e-01 | 0.048 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.962389e-01 | 0.048 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 8.962389e-01 | 0.048 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.966019e-01 | 0.047 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.970028e-01 | 0.047 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.985104e-01 | 0.046 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.030194e-01 | 0.044 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.037936e-01 | 0.044 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.037936e-01 | 0.044 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.037936e-01 | 0.044 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.037936e-01 | 0.044 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.037936e-01 | 0.044 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.052379e-01 | 0.043 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.066032e-01 | 0.043 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.080962e-01 | 0.042 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 9.087064e-01 | 0.042 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.087064e-01 | 0.042 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.087064e-01 | 0.042 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.087064e-01 | 0.042 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.087064e-01 | 0.042 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.107987e-01 | 0.041 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.115974e-01 | 0.040 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.135388e-01 | 0.039 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.140799e-01 | 0.039 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.172940e-01 | 0.037 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 9.172940e-01 | 0.037 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.172940e-01 | 0.037 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.172940e-01 | 0.037 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.172940e-01 | 0.037 | 1 | 1 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.187926e-01 | 0.037 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 9.191554e-01 | 0.037 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 9.206380e-01 | 0.036 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.233168e-01 | 0.035 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.233168e-01 | 0.035 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.233168e-01 | 0.035 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.235201e-01 | 0.035 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.239477e-01 | 0.034 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.250864e-01 | 0.034 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.255735e-01 | 0.034 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.274746e-01 | 0.033 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.284712e-01 | 0.032 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.284712e-01 | 0.032 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.289013e-01 | 0.032 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 9.289013e-01 | 0.032 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.289013e-01 | 0.032 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 9.327395e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.327395e-01 | 0.030 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.339774e-01 | 0.030 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.340794e-01 | 0.030 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.340794e-01 | 0.030 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 9.350032e-01 | 0.029 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.366992e-01 | 0.028 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.366992e-01 | 0.028 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.367660e-01 | 0.028 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.367660e-01 | 0.028 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.371642e-01 | 0.028 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 9.388807e-01 | 0.027 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.388807e-01 | 0.027 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.388807e-01 | 0.027 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.388807e-01 | 0.027 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.388807e-01 | 0.027 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 9.388807e-01 | 0.027 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.395122e-01 | 0.027 | 1 | 1 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.403805e-01 | 0.027 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.447919e-01 | 0.025 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.485596e-01 | 0.023 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.491798e-01 | 0.023 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.506957e-01 | 0.022 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.512878e-01 | 0.022 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.512878e-01 | 0.022 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.512878e-01 | 0.022 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.512878e-01 | 0.022 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.521264e-01 | 0.021 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.521264e-01 | 0.021 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.521264e-01 | 0.021 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.548366e-01 | 0.020 | 1 | 1 |
| Gap junction assembly | R-HSA-190861 | 9.548366e-01 | 0.020 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.548366e-01 | 0.020 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.548366e-01 | 0.020 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.558269e-01 | 0.020 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.565106e-01 | 0.019 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 9.581270e-01 | 0.019 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.581270e-01 | 0.019 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.591660e-01 | 0.018 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.591660e-01 | 0.018 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.611779e-01 | 0.017 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.611779e-01 | 0.017 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.611779e-01 | 0.017 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.611779e-01 | 0.017 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 9.611779e-01 | 0.017 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.640067e-01 | 0.016 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.640067e-01 | 0.016 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.640178e-01 | 0.016 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.640887e-01 | 0.016 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.656675e-01 | 0.015 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.658666e-01 | 0.015 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.662310e-01 | 0.015 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.662310e-01 | 0.015 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.662310e-01 | 0.015 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.666334e-01 | 0.015 | 1 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.683608e-01 | 0.014 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.689632e-01 | 0.014 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 9.689632e-01 | 0.014 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.690613e-01 | 0.014 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.690613e-01 | 0.014 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.690613e-01 | 0.014 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.692525e-01 | 0.014 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 9.692525e-01 | 0.014 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.702709e-01 | 0.013 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.702709e-01 | 0.013 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.713161e-01 | 0.013 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.713161e-01 | 0.013 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.721119e-01 | 0.012 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.723227e-01 | 0.012 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.731762e-01 | 0.012 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.732729e-01 | 0.012 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.734066e-01 | 0.012 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.734066e-01 | 0.012 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.734066e-01 | 0.012 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.737479e-01 | 0.012 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.753450e-01 | 0.011 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.753450e-01 | 0.011 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.753450e-01 | 0.011 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.754635e-01 | 0.011 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.769982e-01 | 0.010 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.771421e-01 | 0.010 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.771421e-01 | 0.010 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.771421e-01 | 0.010 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 9.771421e-01 | 0.010 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.774790e-01 | 0.010 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.775701e-01 | 0.010 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.780690e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.780690e-01 | 0.010 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.780690e-01 | 0.010 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.784345e-01 | 0.009 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.787880e-01 | 0.009 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.788083e-01 | 0.009 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.788083e-01 | 0.009 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 9.794839e-01 | 0.009 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.795340e-01 | 0.009 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.798973e-01 | 0.009 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.803532e-01 | 0.009 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.803532e-01 | 0.009 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.803532e-01 | 0.009 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 9.803532e-01 | 0.009 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 9.803532e-01 | 0.009 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.803532e-01 | 0.009 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.805948e-01 | 0.009 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.806931e-01 | 0.008 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.808502e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.810511e-01 | 0.008 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.818782e-01 | 0.008 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.822411e-01 | 0.008 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.829193e-01 | 0.007 | 1 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.829519e-01 | 0.007 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.831135e-01 | 0.007 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.831135e-01 | 0.007 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.843448e-01 | 0.007 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.843448e-01 | 0.007 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.843448e-01 | 0.007 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.844073e-01 | 0.007 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.846071e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.846688e-01 | 0.007 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 9.857727e-01 | 0.006 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.859825e-01 | 0.006 | 1 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.863158e-01 | 0.006 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.865992e-01 | 0.006 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.874737e-01 | 0.005 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.875259e-01 | 0.005 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.875259e-01 | 0.005 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.879960e-01 | 0.005 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.885952e-01 | 0.005 | 1 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.886515e-01 | 0.005 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.887590e-01 | 0.005 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 9.890063e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.894745e-01 | 0.005 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 9.901456e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.907861e-01 | 0.004 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.908801e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.914582e-01 | 0.004 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.915928e-01 | 0.004 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.916336e-01 | 0.004 | 1 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.919177e-01 | 0.004 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 9.920814e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.925501e-01 | 0.003 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.936912e-01 | 0.003 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.938033e-01 | 0.003 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.940614e-01 | 0.003 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.945784e-01 | 0.002 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 9.945784e-01 | 0.002 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.949740e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.955389e-01 | 0.002 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.956809e-01 | 0.002 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.956809e-01 | 0.002 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.957238e-01 | 0.002 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.957567e-01 | 0.002 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.959962e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.962884e-01 | 0.002 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.963728e-01 | 0.002 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.964625e-01 | 0.002 | 1 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.965594e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.965594e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.965594e-01 | 0.001 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.966089e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.966089e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.968106e-01 | 0.001 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.970544e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.972303e-01 | 0.001 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.972593e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.974594e-01 | 0.001 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.974594e-01 | 0.001 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.975808e-01 | 0.001 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 9.975808e-01 | 0.001 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 9.975808e-01 | 0.001 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 9.975808e-01 | 0.001 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.975808e-01 | 0.001 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.976806e-01 | 0.001 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.977014e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.977393e-01 | 0.001 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.979616e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.979764e-01 | 0.001 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.981241e-01 | 0.001 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.981251e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.981405e-01 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.982301e-01 | 0.001 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.984153e-01 | 0.001 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.984823e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.985059e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.985059e-01 | 0.001 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 9.985958e-01 | 0.001 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.986151e-01 | 0.001 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.986527e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.986549e-01 | 0.001 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.986885e-01 | 0.001 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.986981e-01 | 0.001 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.987162e-01 | 0.001 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.987538e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.988075e-01 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.988448e-01 | 0.001 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 9.988448e-01 | 0.001 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 9.988562e-01 | 0.000 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.989020e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.989319e-01 | 0.000 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 9.989319e-01 | 0.000 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.990027e-01 | 0.000 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.990027e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.990027e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.990523e-01 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.991088e-01 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.991088e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.991306e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 9.991883e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.992420e-01 | 0.000 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.992615e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 9.993397e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.993504e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.993837e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.993837e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.994370e-01 | 0.000 | 1 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.994404e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.994632e-01 | 0.000 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 9.995325e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 9.995325e-01 | 0.000 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.995564e-01 | 0.000 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 9.996085e-01 | 0.000 | 1 | 0 |
| Collagen formation | R-HSA-1474290 | 9.996189e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 9.996202e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 9.996202e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.996969e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.996969e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998353e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 9.998870e-01 | 0.000 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.998870e-01 | 0.000 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.999013e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999100e-01 | 0.000 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.999245e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999475e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999501e-01 | 0.000 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 9.999535e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999639e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999649e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999690e-01 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.999802e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999855e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.999868e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999903e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999949e-01 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.999951e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999952e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999974e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999989e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999990e-01 | 0.000 | 1 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999992e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999997e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999998e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000e+00 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000e+00 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.000000e+00 | 0.000 | 1 | 1 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 1.000000e+00 | 0.000 | 1 | 1 |